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PREFACE 
Voltage-gated calcium channels play a key role in many neuronal functions, 
including controlling electrical excitability and triggering neurotransmitter release. 
Retinal bipolar cells have been known to possess both LVA and HVA calcium currents. 
Previous immunostaining and electrophysiological recordings suggest a heterogeneous 
expression of different types of calcium channels among different bipolar cells. The 
detailed molecular and electrophysiological properties of the calcium currents in specific 
bipolar cell types, however, remain largely unknown. In this study, I investigated the 
electrophysiological and molecular properties of HVA calcium currents in bipolar cells, 
especially rod bipolar cells, in the mouse retina. 
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CHAPTER 1 Background and rationale 
Roles of retinal bipolar cells in visual information processing 
It is well known that visual information is processed through the retina in parallel fashion 
(Wu et al., 2000; Wassle, 2004). Retinal bipolar cells (BCs), the second order cells in the retina, 
not only relay visual signals from rod and cone photoreceptors to retinal third order neurons, 
amacrine and ganglion cells, but also play an important role in parallel visual processing in the 
retina. In mammals, there is one type of rod bipolar cell (RBC) and at least nine types of cone 
bipolar cells (CBCs) based on their terminal stratification at the inner plexiform layer (IPL) 
(Ghosh et al., 2004; Pignatelli and Strettoi, 2004). More recently, additional subtypes of CBCs 
have been revealed based on the expression of intrinsic membrane channels and other molecular 
markers (Jakobs et al., 2003; Fyk-Kolodziej and Pourcho, 2007; Mataruga et al., 2007; Cui and 
Pan, 2008). 
The existence of multiple BC types is believed to be the important anatomical substrate 
for segregating visual information into parallel pathways. For example, at the BC level, visual 
signals are segregated into ON and OFF pathways, carried by ON- and OFF-BCs with ON-BCs 
responding to light increase with membrane depolarization and OFF-BCs to light increase with 
membrane hyperpolarization.  
BCs are also divided into RBCs and CBCs for processing scotopic and photopic visual 
signals, respectively. Furthermore, the light response waveforms from BCs to third order cells 
become ever more diversified (Euler and Masland, 2000). The appearance of the diversified 
response properties in BCs and third order neurons is believed to relate to increasing complexity 
of visual processing from photoreceptors to ganglion cells. The occurrence of the diversified 
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light responses in inner retinal neurons (second and third order retinal neurons) has been reported 
to originate in part at the level of BCs, possibly due to their diversified response waveforms and 
neurotransmitter release (Awatramani and Slaughter, 2000; Berntson and Taylor, 2000; Euler 
and Masland, 2000).  
Indeed, previous studies have reported that BCs of different types use multiple subtypes 
of glutamate receptors at their dendrites to filter the visual signal from photoreceptors into 
different functional groups of BCs (DeVries, 2000). For example, in the primate retina OFF type 
BCs contacting medium wavelength (M) and long wavelength (L) sensitive cones, express 
AMPA glutamate receptors. At the other hand, those BCs receiving information of short 
wavelength (S), express kainite-type glutamate receptors.  
In addition, increasing evidence suggests that voltage-dependent membrane channels 
contribute to the diverse physiological properties of BCs (Burrone and Lagnado, 1997; Mao et al., 
1998; Protti et al., 2000; Ma et al., 2005). The BCs of different types have been known to 
express heterogeneous properties of voltage-gated membrane currents, including voltage-gated 
Ca2+ currents (Pan, 2000), potassium (K+) currents (Hu and Pan, 2002), sodium (Na+) currents 
(Pan and Hu, 2000), inwardly rectifying K+ currents and hyperpolarization-activated cyclic 
nucleotide-gated inward currents (HCN or h-currents) (Ma et al., 2003; Muller et al., 2003). 
Voltage-gated Ca2+ channels could be particularly important in governing the physiological 
properties of retinal BCs, because the influx of Ca2+ current can be directly involved in 
regulating synaptic signal integration, shaping response waveform, as well as triggering 
neurotransmitter release.  
Molecular composition and functions of voltage-gated Ca2+ channels 
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Voltage gated Ca2+ channels selectively mediate Ca2+ influx, being involved in numerous 
physiological processes such as muscle contraction, hormone secretion, gene transcription, and 
synaptic transmission. Voltage-gated Ca2+ channels are heteromultimeric protein complexes 
consisting of a α1 subunit, as well as auxiliary β, α2δ, and possibly γ subunits (Scheme 1A) 
(Hofmann et al., 1994). Ten α1, four β (β1-4), four α2δ (α2δ1-4), and eight γ (γ1-8) subunits have 
been cloned (Scheme. 1A). The α1 subunit of 190 to 250 kDa, forms the ion flowing pore and 
contains the ion selectivity filter and voltage sensors which gate the channels in response to 
changes in membrane potentials and primarily determines biophysical and pharmacological 
properties of the channel (Catterall, 2000). Moreover, the α1 subunit is the major target of 
regulatory molecules, drugs and toxins (Catterall et al., 2007). Auxiliary subunits facilitate 
membrane targeting of the α1 subunit and influence channel kinetics such as voltage-dependent 
activation and inactivation (Neely et al., 1993; Tareilus et al., 1997; Yasuda et al., 2004). 
Intracellular β subunit is a hydrophilic protein, composed of a SH3 (Src homology-3) domain 
and a guanylate kinase (GK) domain. The β subunit binds with α subunit via a GK domain 
interaction (Catterall et al., 2013). The α2δ subunit is encoded by a single gene. After it is post 
translationally cleaved, forms disulfide-bond to the plasma membrane and is anchored, the α2δ 
subunit is mature. Each of subunits also could be subject to unique modulation by endogenous 
modulators.  
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Scheme 1. Schematic illustration of structure of voltage-gated Ca2+ channels. A, The principal α1 subunit is 
a transmembrane protein containing a conducting pore, through which Ca2+ ions can pass upon opening. 
The α1 subunit is further regulated by auxiliary subunits: intracellular β subunit, transmembrane γ subunit 
and a complex of extracellular α2 subunit and transmembrane δ subunit, connected by a disulphide bridge. 
modified from (Lacinova, 2005). B, Diagrammatic representation of the topology of subunits of voltage-
gated Ca2+ channels. Yellow and green cylinders indicate transmembrane segments of α1 subunit. Green 
cylinders indicate the charged S4 segment and yellow indicates the pore region. Orange cylinder 
represents transmembrane segment of δ subunit. Glycosylation is indicated by fork shapes. Modified from 
(Dolphin, 2003). 
 
Table 1. Classification, nomenclature and comparison of voltage gated Ca2+ channels. Modified from Hille, 
Ion Channels of Excitable Membrane, Chapter 4, p117) (Hille, 2001; Dolphin, 2003; Lacinova, 2005). 
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Voltage-gated Ca2+ channels are divided into low-voltage-activated (LVA) and high-
voltage activated (HVA) Ca2+ channels based on their activation threshold (Carbone and Lux, 
1984; Ertel et al., 2000). The HVA Ca2+ channels are further classified into L-type and non-L-
type HVA Ca2+ channels based on pharmacological properties. Low-voltage-activated (LVA) 
Ca2+ channels are also named T-type. 
T-type Ca2+ channel family is encoded by α 1G (Cav3.1), α 1H (Cav3.2) and α 1I (Cav3.3) 
Ca2+ channel subunits (Perez-Reyes, 2003). T-type Ca2+ channels are well known for their roles 
in burst firing and oscillatory behavior in neurons. In chromaffin cells and retinal BCs, T-type 
Ca2+ channels could also mediate transmitter release (Carbone et al., 2006; Pan et al., 2001).  
Based on their sensitivity to 1, 4-dihydropyridine (DHP) class of compounds, HVA Ca2+ 
channels are further divided into two subgroups: L-type and non-L-type HVA Ca2+ channels. L-
type Ca2+ channel family is sensitive to DHP antagonists and agonists, such as nifedipine, 
nimodipine, and BayK8644. They are encoded by α 1S (Cav1.1), α 1C (Cav1.2), α 1D (Cav1.3), 
and α 1F (Cav1.4). L-type Ca2+ channels are present in skeletal muscle, heart, smooth muscle, 
and neurons (Hess et al., 1984; Nowycky et al., 1985). In most neurons in the CNS, L-type 
voltage-gated Ca2+ channels are primarily targeted to dendrites and the cell soma (Catterall, 2000) 
and are responsible for Ca2+ signals for controlling cell excitability, gene transcription, and 
neural plasticity (Graef et al., 1999; West et al., 2001). For example, NMDA receptor-
independent long-term potentiation (LTP) most often requires the activation of L-type Ca2+ 
channels (Grover and Teyler, 1990). L-type Ca2+ channels mediated gene expression and neural 
plasticity are known to be carried through CREB (cyclic AMP response element binding protein), 
a calcium-regulated transcription factor. Specifically, L-type Ca2+ channels trigger 
phosphorylation of CREB through activation of the calmodulin (CaM) kinases and CaM kinase 
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IV (CaMKIV) (Calin-Jageman and Lee, 2008). Thus, through the regulation of CREB, L-type 
Ca2+ channels can potentially regulate a host of genes responsible for a wide range of cellular 
functions, including activity-dependent synaptic plasticity and tropic factor-dependent neuronal 
survival (West et al., 2001).  
The non-L-type HVA Ca2+ channels were subclassified with the aid of several invaluable 
toxins. They are named P/Q (Cav2.1), N (Cav2.2) and R (Cav2.3). N-type Ca2+ channels are 
blocked by ω-conotoxin GVIA (McCleskey et al., 1987). Mintz’s group found that P-type Ca2+ 
channels are blocked by ω-agatoxin IVA and later another subtype, Q-type, were found to be 
sensitive to ω-agatoxin IVA too (Mintz et al., 1992; Wheeler et al., 1995). These two 
components are combined as P/Q. R-type Ca2+ channels are resistant to DHPs, ω-conotoxin 
GVIA and ω-agatoxin IVA (Wheeler et al., 1995). P/Q and N type Ca2+ channels are expressed 
on presynaptic terminals and dendrites in CNS to trigger rapid synaptic transmission (Wheeler et 
al., 1995; Evans and Zamponi, 2006) and mediate dendritic transient Ca2+ influx (Catterall, 
2000). In particular, the P/Q Ca2+ channel is expressed in the cerebellum, particularly in Purkinje 
and granule cells (Lonchamp et al., 2009). R type Ca2+ channel is primarily found to be 
expressed in hippocampus (Westenbroek et al., 1992; Weiergraber et al., 2007), trigeminal 
ganglion nociceptive neurons and dorsal root ganglion neurons (Fang et al., 2010). The functions 
of non-L-type HVA Ca2+ channels are considered to trigger action potential as well as 
neurotransmitter release (Catterall, 2000; Weiergraber et al., 2007). HVA (L-type and DHP-
insensitive HVA) and LVA Ca2+ channels differ in their distinct biophysical and 
pharmacological properties (Table 1).  
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Biophysical and pharmacological properties of L-type voltage gated calcium 
channels 
A hallmark of L-type Ca2+ channels is their slow voltage-dependent inactivation. 
However, the detailed biophysical properties, such as activation threshold, voltage-dependent 
inactivation, calcium-dependent inactivation, and voltage-dependent facilitation are different 
among L-type Ca2+ channels formed by different α1 subunits (Hess et al., 1984; Koschak et al., 
2003). First, among α1C, α1D, and α1F, the α1D exhibits the lowest activation threshold, 
followed by α1F, while the α1C has the highest activation threshold (Koschak et al., 2003). 
Second, these three Ca2+ channels also show different voltage- and Ca2+-dependent inactivation. 
α1C exhibits the fastest voltage- and Ca2+-dependent inactivation followed by α1D. Voltage- and 
Ca2+-dependent inactivation is not apparent in α1F. Finally, these three L-type Ca2+ subunits also 
display different voltage-dependent facilitation (Koschak et al., 2003). 
 Also, although all L-type Ca2+ channels are sensitive to DHP compounds, their 
sensitivity to DHP antagonists and agonists has been reported to be different among different 
subunits (Hess et al., 1984; Nowycky et al., 1985) (Table 1). The α1F shows the lowest 
sensitivity to DHP compared to α1C and α1D. This is because DHPs bind preferentially to the 
inactivated state of channels. The lack of inactivation of α1F Ca2+ channels decreases the 
apparent affinity to DHP compounds. On the basis of their biophysical characteristics and 
intermediate DHP sensitivity, α1D and α1F have also been thought to be classified as a 
functional low-voltage-gated Ca2+ channel subgroup.  
It should be noted that most studies of the biophysical and pharmacological properties of 
L-type Ca2+ channels was carried out in heterologous expression systems, such as in the HEK 
cell line (Koschak et al., 2003). Although these studies provide important insights into the 
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properties of L-type Ca2+ channels, the properties of native L-type Ca2+ channels could be 
different. First, it remains unclear whether or what auxiliary subunits are associated with L-type 
Ca2+ channels in vivo. The presence of auxiliary subunits could alter the properties of L-type 
Ca2+ channels (Koschak et al., 2003). Furthermore, the central nervous system also utilizes 
alternative splicing to support an astounding level of structural and functional diversity in the 
voltage-gated Ca2+ channel family. In different tissue types, there are different L-type Ca2+ 
channel α1 subunit mRNA alternative splicing isoform products (Chien and Hosey, 1998; 
Lipscombe et al., 2002; Tang et al., 2004; Shen et al., 2006; Tang et al., 2007). For example, 
Doering et al ’s study revealed that alternative splicing enables functional α1F subunits to be 
expressed at low levels in the α1F mutant strain (Doering et al., 2008). The presence of multiple 
alternative splicing variants of L-type Ca2+ channel subunits could also alter the properties of L-
type Ca2+ currents.  
Modulation of high voltage gated calcium channel 
Ca2+ plays an essential role in many normal cellular functions, but Ca2+ overloading could 
also induce toxic effects and cell death. Therefore, Ca2+ channels are under restricted regulation 
by multiple mechanisms (Calin-Jageman and Lee, 2008). One type of regulation is feedback 
regulation, mainly Ca2+-dependent inactivation and Ca2+-dependent facilitation (Calin-Jageman 
and Lee, 2008). Both Ca2+-dependent inactivation and Ca2+-dependent facilitation depend on the 
ubiquitous Ca2+-binding protein calmodulin (CaM). CaM can also facilitate trafficking of α1C in 
neurons through binding with the C-terminal of the L-type α1 channel (Wang et al., 2007).  
Voltage-gated Ca2+ channels in general and L-type Ca2+ channels in particular are also 
subject to modulation by many endogenous modulators. The classic modulation is 
phosphorylation, which might be mediated by G-protein coupled receptors (Dascal et al., 1986; 
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Fisher and Johnston, 1990; Dolphin, 2003). For example, Gα can mediate voltage-independent 
Ca2+ channel phosphorylation or dephosphorylation to increase or decrease Ca2+ current. 
Gα/PKA and Gq/PLCβ second messenger pathways could up-regulate N and P/Q Ca2+ currents 
by direct channel phosphorylation. In addition, PKA modulates L-type Ca2+ channel proteins 
through interacting with A-kinase anchoring protein (AKAP), which binds with the L-type Ca2+ 
channel protein C-terminal via a leucine zipper motif. Synaptic proteins, such as syntaxin 1A and 
SNAP-25 bind to the intracellular linker between domains II and III of L-type Ca2+ channel 
proteins (Wiser et al., 1996). Single synaptic proteins inhibit L-type Ca2+ channel function, but 
co-binding of syntaxin 1A and SNAP-25 can induce an activation effect on L-type Ca2+ channel 
proteins (Wiser et al., 1999).  
High voltage gated calcium channels in retinal BCs 
The presence of L-type Ca2+ channels in retinal BCs has been demonstrated by 
electrophysiological recordings based on their sensitivity to DHP compounds (Maguire et al., 
1989; Kaneko et al., 1991; Pan, 2000, 2001). L-type Ca2+ currents have been observed in both 
RBCs and CBCs (Pan, 2000). In particular, the L-type Ca2+ currents in RBCs in rodents were 
found to be located only at the axon terminals (Hartveit, 1999; Pan, 2001), suggesting that they 
are involved in neurotransmitter release in BCs. Indeed, the involvement of L-type Ca2+ channels 
in the transmitter release in BCs has been demonstrated in Mb-1 BCs in goldfish and in RBCs in 
rodents (Heidelberger and Matthews, 1992; Singer and Diamond, 2003; Oltedal and Hartveit, 
2010). In gold fish Mb1 BCs, the L-type Ca2+ channels can generate Ca2+ spikes in the dark-
adapted retina (Protti et al., 2000). 
Interestingly, the involvement of L-type Ca2+ channels in neurotransmitter release in 
retinal neurons (both in BCs and photoreceptors) contrasts to that in the other regions of the CNS 
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where neurotransmitter release is primarily controlled by non-DHP sensitive HVA Ca2+ channels. 
From a functional point of view, this is not surprising. Retinal BCs and photoreceptors belong to 
a small class of sensory neurons, including inner ear hair cells, which mainly use graded 
potential to control neurotransmitter release rather than spikes for signal coding (Barbour et al., 
1994). In contrast to spiking neurons in which the Ca2+ currents are activated by large 
depolarization and then rapid inactivation, the Ca2+ currents of photoreceptors and BCs are 
activated at relatively hyperpolarized potentials and do not significantly inactivate (de la Villa et 
al., 1998; Protti and Llano, 1998). Furthermore, sustained signals, exhibiting little inactivation, 
and a relatively narrow range of membrane potentials are prominent features of this kind of 
sensory cell signals (Wilkinson and Barnes, 1996). Thus, L-type Ca2+ channels with slow 
inactivation would be especially suitable to control graded and sustained neurotransmitter release 
in BCs.  
L-type Ca2+ currents at the axon terminals of the Mb-1 BCs in goldfish and in 
mammalian BCs have also been reported to contribute to the stereotypical spontaneous and/or 
light-evoked waveforms (Heidelberger and Matthews, 1992; Ma and Pan, 2003). 
I am particularly interested in the molecular properties of voltage-gated Ca2+ channels in 
retinal information processing. A differential expression of L-type Ca2+ channel subunits among 
different BCs could have important functional implications for visual signal processing in the 
retina. First, different L-type Ca2+ channels are known to have distinct biophysical properties 
which could result in distinct Ca2+ signaling in different BCs. In addition, different L-type Ca2+ 
channels could be subject to distinct modulation by endogenous modulators, which could result 
in differential regulation of Ca2+ signaling in different BCs, thus the information processing 
pathways at the level of BCs. Furthermore, whether retinal BCs express non-L-type L-type Ca2+ 
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channels remains unknown. Thus, a detailed knowledge of the properties of HVA Ca2+ channels, 
including L-type Ca2+ channels, in different types of retinal BCs could provide important insights 
into the mechanisms of visual information processing in the retina. In addition, the knowledge 
we gain from these studies could also provide insight into Ca2+ signaling and Ca2+ channel 
deficit-related diseases of the visual system. 
Molecular properties of HVA Ca2+ channels in retinal BCs 
Although BCs is known to express only L-type Ca2+ channels, the molecular properties of 
L-type Ca2+ channels in different retinal BCs are largely unclear. Previous studies of the 
molecular properties of the L-type voltage-gated Ca2+ channels in the retina in general and in 
retinal BCs in particular were mainly carried out by immunostaining. The expression of all four 
Ca2+ channel α1 subunits, α1S, α1C, α1D, and α1F, was reported in the retina (Morgans, 1999; 
Morgans et al., 2001; Xu et al., 2002; Berntson et al., 2003).  
The expression of the α1F Ca2+ channel subunit in the retina has been well documented. 
Particularly, α1F is the primary Ca2+ channel in controlling photoreceptor transmitter releasing in 
rod photoreceptors (Berntson et al., 2003). Consistently, mutation of α1F in human can cause 
incomplete X-linked congenital stationary night blindness, a recessive, nonprogressive visual 
disease characterized by poor night vision and decreased visual acuity (Miyake et al., 1986). One 
early study also suggests that α1F subunits are expressed in rod BCs, especially at the axon 
terminals (Berntson et al., 2003).  
α 1D is known to be predominantly expressed in cochlea hair cells (Kollmar et al., 1997). 
In the retina, Ca2+ channels in cone photoreceptors were suggested to be α 1D (Morgans et al., 
2005). Abundant L-type Ca2+ channel α1D subunit mRNA expression was confirmed in most 
cells of the inner nuclear layer in the mouse retina (Xiao et al., 2007). The peak of the 
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electroretinogram was reported to be altered in α1D subunit knockout mice (Wu et al., 2007). It 
remains unknown whether α1D contribute to the L-type Ca2+ currents in BCs.  
Immunostaining studies also reported the expression of the α1C Ca2+ channel subunit in 
retinal BCs (Xu et al., 2002; Specht et al., 2009). Especially, the whole RBCs, including 
dendrites, the cell soma and axon terminals, show immunoactivity against α1C Ca2+ channels 
antibody. Interestingly, this contrasts to the electrophysiological results in which L-type Ca2+ 
currents were only observed in the axon terminals. The reasons for the discrepancy between the 
immunostaining and electrophysiological results remain to be investigated. 
The expression of α1S was recently reported to be expressed on dendritic terminals of 
ON-BCs (Specht et al., 2009), suggesting it could be involved in synaptic signal integration of 
BCs. 
It also remains largely unclear whether auxiliary subunits are associated with L-type Ca2+ 
channels in retinal BCs in vivo. The expression, biophysical and pharmacological properties 
could be significantly influenced by the auxiliary subunits, notably the β subunits. For example, 
co-expression of β subunits can increase DHP agents’ binding and affinity. The key role of the 
β2 subunit has been demonstrated by a recent study showing that elimination of this subunit in 
mouse retina produces a phenotype similar to X-linked congenital stationary night blindness in 
humans (Ball et al., 2002). The finding indicates that the β2 subunit is obligatorily required for 
the formation of native retinal L-type Ca2+ channels. On the other hand, no retinal phenotype has 
been reported so far for other β subunit-deficient mice. 
The detailed biophysical and pharmacological properties of L-type Ca2+ channels in 
retinal BCs have not been investigated. In retinal BCs of different species, DHP-sensitive Ca2+ 
currents were found to possess properties not typically found for L-type currents in cardiac 
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myocytes (Adachi-Akahane et al., 1999) or neurons (Sinnegger-Brauns et al., 2009).  These were 
described as faster activation, slower inactivation, negative activation thresholds, and 
intermediate DHP sensitivity. These properties were thought to be the properties of α1D. 
However, the more recently discovered α1F also exhibits similar properties.  
The heterogeneous properties of L-type Ca2+ currents among different BCs were 
observed in previous results in our laboratory from isolated BCs (Pan, 2000). This together with 
immunostaining results reported by others led us to hypothesize that there is a differential 
expression of L-type Ca2+ channels among different types of BCs. To test the hypothesis, I will 
investigate the biophysical properties of HVA Ca2+ channels among different BCs. In particular, 
I will investigate the molecular identity of Ca2+ channels in RBCs. 
Using L-type Ca2+ channel KO mice  
The characterization of the properties of L-type Ca2+ channels in BCs has been hampered 
by several factors. First, although a number of antibodies have been available for L-type Ca2+ 
channels, most of the antibodies for L-type Ca2+ channels, except α1F, have not been validated in 
knockout animals and thus make the interpretation of the immunostaining data inconclusive. 
Second, multiple splicing variants of L-type Ca2+ channels could exist, and some of them may 
not display the conventional biophysical and pharmacological properties of known L-type 
(Murbartian et al., 2002). Furthermore, since there are about ten types of BCs, the lack of 
biomarkers for specific BC types makes the electrophysiological studies of a specific BC type 
difficulty.  
The recent availability of several L-type Ca2+ channel KO or mutant mice and several BC 
type specific GFP transgenic mice has provided valuable tools for the study of the properties and 
functions of L-type Ca2+ channels (Moosmang et al., 2007). First, a spontaneous α1F mutant 
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mouse is available from Jackson Laboratory. In addition, conventional α1D KO and conditional 
α1C KO mice have been produced (Platzer et al., 2000; White et al., 2008). Both mice are viable 
and did not show gross abnormality of retinal anatomy. In these studies, I will take advantage of 
these L-type Ca2+ channel knockout and mutant mice. The L-type Ca2+ channel KO and mutant 
mice could enable us to validate the molecular composition of L-type Ca2+ channel α1 subunits 
in the retina and in retinal BCs.  
Characterization of fluorescence protein-expressing retinal BCs in transgenic mouse 
lines 
The second factor that hampers the study of Ca2+ current in BCs is the lack of BC 
specific markers. In particular, markers that can be used to identify BC types for in vitro 
electrophysiological studies are lacking.  
Several immunocytochemical markers for BCs are discovered to label specific BC types 
(Wassle et al., 2009). However, most of them are not suitable for in vitro labeling except CD15, 
which labels type 2 BCs of mice. For example, protein kinase C (PKCα) is RBC marker. 
Synaptotagmin 2 (Syt2) is type 2 and type 6 CBC marker. 
Recently, the generation of transgenic mice with green fluorescence protein (GFP) 
expression has become an alternative approach to identify cell types in the CNS and the retina 
(Gong et al., 2003). Several transgenic mouse lines in which specific retinal BC type (s) labeled 
with fluorescence proteins have been previously described, such as ON BCs (Morgan et al., 2006; 
Dhingra et al., 2008), type 7 CBCs (Wong et al., 1999; Huang et al., 2003), and type 9 CBCs 
(Haverkamp et al., 2005), and, more recently, type 5 CBCs (Wässle et al., 2009). The 
development of more BC type specific GFP or Cre transgenic mouse line will facilitate the in 
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vitro electrophysiological recordings of specific retinal BC types. In this study, we have 
characterized a GFP transgenic mouse line, 5HTR2a-GFP. In this line, type 4 CBCs are 
selectively labeled by GFP. 
 
Table 2. BC types of the mouse retina and the markers and transgenic mouse lines used in the present 
study modified from (Wassle et al., 2009).  
Characterization of Cre recombinase expressing pattern in transgenic mouse lines 
The third factor that hampers the study of Ca2+ current in BCs is the lack of BC specific 
knockout systems for in vitro electrophysiological studies. There are two reasons for us to further 
characterize Cre-transgenic animal lines such as follows: (1) This provides another approach for 
BC identification. (2) Cre recombination can be used to knockout genes in specific cell types. 
The manipulation of gene expression in specific BC type (s) in the retina is able to 
investigate the molecular mechanisms of physiological and pathological properties of BCs. The 
powerful Cre/LoxP recombination system has become one of the approach to control gene 
expression in vivo (Nagy, 2000; Branda and Dymecki, 2004), especially with the increasing 
availability of cell- and tissue-specific Cre transgenic mouse lines (Gaveriaux-Ruff and Kieffer, 
2007; Gong et al., 2007). A widely used conditional gene-targeting approach is to cross cell- and 
tissue-specific Cre transgenic mouse lines with Cre-dependent reporter or conditional mouse 
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lines. Cre transgenic lines, especially those produced by conventional methods (via pronuclear 
injection), are subject to the local chromatin environment (i.e., position effect), which could lead 
to transgene silencing or variable ectopic expression (Milot et al., 1996; Williams et al., 2008; Le, 
2011; Smith, 2011). To specialize and evaluate the utility of Cre-mediated reporter gene 
expression require in vivo screen of the expression pattern and recombination efficiency in detail. 
Cre-dependent virus-mediated gene delivery is another powerful approach that can be used to 
target a transgene to Cre-expressing cells in transgenic mouse lines (Schnutgen et al., 2003; 
Atasoy et al., 2008; Kuhlman and Huang, 2008).  
Recombinant adeno-associated virus (rAAV) vectors have been particularly widely used 
in retinal gene transfer (Surace and Auricchio, 2008). Due to their anatomical location in the 
middle of the retina, however, retinal BCs are the most inaccessible cell types in the retina to 
virus transduction. The ability of the Cre-dependent rAAV vector-mediated transgene delivery to 
retinal BCs in Cre transgenic mouse lines has not been examined. 
So far, only a small number of retinal BC-expressing Cre transgenic mouse lines have 
been reported (Barski et al., 2000; Rowan and Cepko, 2004; Saito et al., 2005; Zhang et al., 2005; 
Ivanova et al., 2010; Nickerson et al., 2011). Most of them were driven by the Pcp2 (Purkinje 
cell protein 2) promoter, a gene that is known to target Purkinje cells in the cerebellum as well as 
in retinal RBCs (Oberdick et al., 1990). Few Cre transgenic lines have been reported to target 
retinal cone BCs. One of them is Chx10-cre, which was reported to target the Cre recombinase in 
multiple retinal BC types (Rowan and Cepko, 2004).  
In this study, we examined the Cre-mediated recombination expression profiles of three 
retinal BC-expressing Cre-transgenic lines, 5-HTR2a-cre, Pcp2-cre, and Chx10-cre, by crossing 
these lines to a strong Cre reporter mouse line. We characterized the Cre-mediated expression 
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patterns in multiple BC types in the 5-HTR2a-cre and Pcp2-cre mouse lines. We also examined 
the ability and transduction efficiency of Cre-dependent rAAV-mediated transgene delivery to 
BCs of the BC-expressing transgenic lines. We found that a Cre-dependent rAAV2/2 vector 
using cytomegalovirus (CMV) promoter and containing a capsid mutation of Y444F is capable 
of achieving Cre-mediated transgene expression in retinal BCs.  
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CHAPTER 2 Characterization of GFP-expressing retinal 
cone bipolar cells in a 5-HTR2a transgenic mouse line 
SUMMARY 
Retinal BCs relay visual information from photoreceptors to ganglion cells. The various 
types of BCs are involved in the segregation of visual information into multiple parallel 
pathways within the retina. Finding molecular markers that can label specific retinal BCs could 
greatly facilitate the investigation of BC functions in the retina. The transgenic approaches of 
expressing green fluorescence protein (GFP) in specific cell type(s) enable studies for the 
morphology and function of specific cell types in the CNS and the retina. In this study, we report 
a 5-hydroxytryptamine-2a (5-HTR2a) transgenic mouse line in which the expression of GFP 
fluorescence was observed in two populations of BCs in the retina. Based on the terminal 
stratification and immunostaining, the majority of the GFP labeled BCs were found to be type 4 
CBCs. In addition, a small number of weakly labeled BCs were also observed, which might be 
type 8 or 9 CBCs. The expression of GFP in retinal CBCs was seen as early as on postnatal day 5. 
In addition, despite the severe retinal degeneration due to carrying an rd1 (or Pde6brd1) gene in 
this transgenic line, the densities of the GFP labeled CBCs were stable up to at least six months 
of the age. This transgenic mouse line will be a useful tool for the study of type 4 cone BCs in 
the retina under normal as well as different disease conditions.  
Key words: Green fluorescence protein, type 4 cone bipolar cell, retina, 5-HTR2a, 
transgenic mouse. 
INTRODUCTION 
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Retinal BCs, the second order neurons in the retina, relay visual information from 
photoreceptors to retinal third-order neurons. BCs comprise multiple types which are essential 
for segregating visual information into multiple parallel pathways in the retina (Wu et al., 2000; 
Wassle, 2004). BCs are subdivided into ON- and OFF-types based on their light response 
polarity and are also subdivided into rod and cone BCs based on their synaptic inputs. In 
mammals, a single type of RBC (Dowling and Boycott, 1969; Boycott and Kolb, 1973; Dacheux 
and Raviola, 1986) and about nine types of CBCs have been described primarily based on their 
terminal stratification at the inner plexiform layer (Famiglietti, 1981; Kolb et al., 1981; Pourcho 
and Goebel, 1987; Euler and Wassle, 1995; Ghosh et al., 2004; Pignatelli and Strettoi, 2004; 
Wassle et al., 2009). In addition to their distinct morphological properties and, likely, unique 
synaptic connections with photoreceptors and third order retinal neurons, increasing evidence 
also suggests that BCs of each type express a distinct array of membrane channels and receptors 
(DeVries, 2000; Pan and Hu, 2000; Hu and Pan, 2002; Muller et al., 2003; Ma et al., 2005; 
Ivanova and Muller, 2006; Fyk-Kolodziej and Pourcho, 2007). Thus, the detailed 
characterization of the anatomical and physiological properties of individual BC types could 
provide important insights into the functional roles of retinal BCs in retinal processing. Finding 
BC specific markers could facilitate such studies.  
The transgenic approaches of expressing green fluorescence protein (GFP) in specific cell 
type(s) enable studies for the morphology and function of specific cell types in the CNS and the 
retina (Gong et al., 2003). Several transgenic mouse lines in which specific retinal BC type (s) 
labeled with fluorescence proteins have been previously described, such as ON BCs (D'Hooge et 
al., 2003; Morgans et al., 2006), type 7 CBCs (Miller et al., 1999; Huang et al., 2003), and type 9 
CBCs (Haverkamp et al., 2005), and, more recently, type 5 CBCs (Wassle et al., 2009) . In this 
20 
 
 
 
study, we report a 5-hydroxytryptamine-2a receptor (5-HTR2a) transgenic mouse line in which 
strong GFP expression was found in type 4 cone BCs. 
METHODS 
Animals 
5-HTR2A-EGFP transgenic mice were obtained from Mutant Mouse Regional Resource 
centers (MMRRC; Line: DQ118). The transgenic mice were generated by homologous 
recombination with a bacterial artificial chromosome (BAC) containing the promoter of 5-
HTR2A receptor with the 5-HTR2A receptor coding sequence being replaced by a sequence 
encoding the EGFP reporter gene (Gong et al., 2003). All animal-handling procedures were 
approved by the Institutional Animal Care and Use Committee at Wayne State University and 
were in accord with the NIH Guide for the Care and Use of Laboratory Animals. Most of the 
experiments were carried out on mice at the age of one month unless otherwise indicated. 
Immunocytochemical staining  
Mice were deeply anesthetized with CO2 and decapitated. The retinas were fixed in the 
eyecups with 4% paraformaldehyde in 0.1 M phosphate buffer (PB) for 20 minutes. The GFP 
fluorescence without enhancement by antibody staining was sufficient to visualize the GFP 
labeled cells. The expression of GFP in the retina was examined in retinal whole-mounts and 
vertical sections. For whole-mounts, after fixation the retina was dissected free in PB solution, 
flat mounted on slides, and cover slipped. For retinal vertical sections, the retinas were 
cryoprotected in a sucrose gradient (10%, 20%, and 30% w/v in PB, respectively), and cryostat 
sections were cut at 20 μm.  
To identify the GFP expressing cell types, the GFP fluorescence was enhanced by 
applying antibodies against GFP and the GFP labeled cells were co-stained with other retinal cell 
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specific antibodies. The following antibodies were used in this study: rabbit anti-GFP (1:2000; 
Molecular Probes); mouse anti-GFP (1:2000; Neuromab); goat anti-choline acetyl transferase 
(CHAT, 1:2000; Chemicon); rabbit anti-HCN4 (1:500; Alomone Labs); mouse anti-protein 
kinase A (1:80000; BD); mouse anti-calsenilin (1:2000; W. Wasco, Harvard Medical School); 
mouse anti-synaptotagmin II (Syt-2; 1:600; Nalgene); rabbit anti-serotonin 2A receptor (1:800; 
Immunostar). 
For immunostaining, retinal whole-mounts or sections were blocked for 30 mins in a 
solution containing 5% Chemiblocker (membrane-blocking agent, Chemicon), 0.5% Triton X-
100 and 0.05% sodium azide (Sigma). The primary antibodies were diluted in the same solution 
and the whole mount retinas were immersed in overnight followed by incubation (1 h), and in the 
secondary antibodies which were conjugated to Alexa 555 (1:600; red fluorescence, Molecular 
Probes) and Alexa 488 (1:600, green fluorescence, Molecular Probes). All steps were carried out 
at room temperature (RT).  
All images were made under a Zeiss Axioplan 2 microscope with the Apotome 
oscillating grating to reduce out-of-focus stray light. Individual cells were selected and Z-stacks 
images were captured using the Zeiss Apotome microscope. Image projections were made by 
collapsing individual z-stacks of optical sections into a single plane unless otherwise specifically 
indicated. The brightness and the contrast were adjusted to acquire optimal signals with Adobe 
Photoshop CS4.  
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Table 3. Primary and secondary antibody lists 
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RESULTS 
GFP expression was observed in the retina of the GFP-transgenic mouse line under the 
control of 5-HTR2a promoter. In retinal whole-mounts, GFP labeled cell somas were observed 
throughout the entire retina with the focal plane at the inner nuclear layer (INL) (Fig. 1A). Most 
of the cell somas were brightly labeled. Some weakly labeled cells were also observed. When 
examined in retinal vertical section, the labeled cells located in the (INL) were found to be BCs 
based on their morphological characteristics (Fig. 1B). The somas of the labeled cells were 
located in the distal portion of the INL with their dendrites and axon terminals extending into the 
outer plexiform layer (OPL) and the inner plexiform layer (IPL), respectively. The vast majority 
of the labeled axon terminals ramified in the distal portion of the IPL. Some axon terminals were 
found to ramify in the inner portion of the IPL but they are barely visible without antibody 
staining (see below). In addition, some weakly labeled cells located in the retinal ganglion cell 
layer were observed (see Fig. 1B).  
It should be noted that since the 5-HTR2a transgenic mice were generated in a FVB/N-
Swiss Webster hybrid background which carries an rd1 (or Pde6brd1) gene (Bowes et al., 1990), 
these mice displayed rapid retinal degeneration. Only a single layer of photoreceptor cell bodies 
remained at the age of one month (see the Nomarski micrograph in the left panel of Fig. 1B). 
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Figure 1. GFP labeled cells in the 5-HTR2a transgenic mouse line. A, GFP labeled cells viewed in retinal 
whole-mount. B, GFP labeled cells viewed in retinal vertical section. Left panel in B shows the Nomarski 
micrograph. Scale bars: 25 μm. 
 
Figure 2. GFP labeled retinal BCs after the enhancement by anti-GFP antibody. A, GFP labeled cells 
viewed in retinal whole-mount with the focal plane at the INL. B, GFP labeled cells were co-labeled with 
anti-CHAT antibody (red) viewed in retinal vertical section. The weakly GFP labeled axon terminals located 
in the proximal portion of the IPL are identified by an arrow the axon is identified by an arrowhead.  C, 
Whole-mount view of the dendritic trees of the GFP labeled CBCs with stacked image that captured both 
cell somas and dendrites. D, Whole-mount view of the axon terminals of the labeled CBCs with the focal 
plane at the IPL. The images of C and D were taken at the same field. Scale bars: 25 μm. 
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To examine the labeled BCs in more detail, GFP fluorescence was enhanced by an 
antibody to GFP. Again, cell somas with strong and weak GFP expression were observed in 
retinal whole-mounts with the focal plane at the INL (Fig. 2A). Figure 2B shows the double 
staining with an antibody to choline acetyltransferase (CHAT) in retinal vertical section. Clearly, 
the strongly GFP-labeled axon terminals ramified in sublamina 1 and 2 of the IPL. The weakly 
GFP-labeled axon terminals stratified in sublamina 4 and 5 (an axon is identified by an 
arrowhead the axon terminals are identified by an arrow in Fig. 2B). Figure 2C shows a stacked 
image in retinal whole-mount that captured both cell somas and dendrites. Each cell soma sends 
out several dendritic branches with distal apical terminals, presumably forming contacts with 
photoreceptor cells. Figure 2D shows a stacked image focusing on the distal portion of the IPL 
that was taken at the same field as in figure 2C. The terminal arborizations of individual BCs are 
clearly visible.  
Based on the previously reported classification of retinal BCs (Ghosh et al., 2004) , the 
strongly GFP labeled BCs with their axon terminals ramifying in sublamina 1 and/or 2 should be 
OFF type CBCs whereas those weakly labeled BCs with their axon terminals ramifying in 
sublamina 4 and 5 should be ON type BCs. To identify the BC types, we co-stained GFP-
positive cells with several BC-specific antibodies. First, the GFP-labeled BCs were not found to 
be stained by an anti-recoverin antibody (Fig. 3A-C) which labels type 2 CBCs in the mouse 
retina (Haverkamp et al., 2003). Second, the GFP-labeled BCs were not co-stained with an anti-
HCN4 antibody (Fig. 3D-F). In addition, the GFP labeled BCs were not co-stained with an anti-
PKARIIβ antibody (Fig. 3G-I) with the exception of a few cells (such as the cell identified by an 
arrow in Fig. 3G and H). HCN4 and PKARIIβ were reported to label two subtypes of type 3 
CBCs (Mataruga et al., 2007). Furthermore, the GFP labeled BCs were negative to an anti-
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synaptotagmin II (Syt-2) antibody (Fig. J-L). The anti-Syt 2 antibody has been reported to label 
type 2 (Fox and Sanes, 2007) and type 6 BCs (Wassle et al., 2009). The enlarged images in the 
insertions of Figure J-L show the lack of co-localization of the Syt-2 positive axon terminals and 
the weakly GFP labeled axon terminals in the lamina 5 and 6. These results suggest that the GFP 
expressing BCs are not type 2, 3, or 6.  
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Figure 3. Double immunostaining using GFP and retinal BC specific antibodies. A-C, Retinal vertical 
section was immunostained for GFP in A and recoverin in B. The superimposition of A and B in C. The 
double immunostaining for GFP and HCN4 in D-F, for GFP and PKARIIβ in G-I and for GFP and Syt-2 in J-
L. The enlarged insertions in the bottom-right of J-L are single z-section images. Scale bars: 25 μm. 
On the other hand, we found that the majority of the GFP-labeled BCs were stained by an 
anti-calsenilin antibody, which was reported to stain type 4 CBCs (Haverkamp et al., 2008). 
Figure 4A-C shows the co-staining of GFP-positive cells with calsenilin in retinal whole-mount 
with the focal plane at the INL. The majority of the GFP labeled cells including all the strongly 
labeled cell somas and a small portion of the weakly labeled cell somas were positive for 
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calsenilin. The co-localization of the GFP and calsenilin positive BCs (cell soma) was also 
apparent in vertical section (Fig. 4D-F). This result indicates that the majority of the GFP-label 
BCs, including all strong GFP-labeled BCs, are type 4 CBCs. In addition, in both whole-mounts 
and retinal vertical sections, all calsenilin-positive cells were found to express GFP, suggesting 
that all type 4 cells are labeled by GFP. The cell densities for the calsenilin positive and negative 
cells at the ages of one month and 6 months were counted and the values are shown in Table 4. 
The cell densities for the calsenilin-positive (type 4) and negative cells were not found to be 
significant different between the ages of 1 month (wholemount retina; n = 12 retinas; n = 6 mice) 
and 6 months (wholemount retina; n = 10 retinas; n = 5 mice). 
To examine the developmental and age-dependent expression of GFP in this transgenic 
line, the expression of GFP was examined from postnatal day 5 to 6 months of age. As shown in 
Figure 5A, the expression of GFP in the INL was already observed at postnatal day 5, although 
only a few GFP labeled cells were observed in the INL at this time point. At P7, many GFP 
labeled cone BCs were clearly seen (Fig. 5B). As a note, the photoreceptor cells were present at 
these early postnatal ages. Figure 5C-D shows the expression of GFP in the retinas at the ages of 
two weeks, one month, and 6 months. The expression was persistent up to at least at the age of 6 
months, the oldest animals that were checked in this study.   
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Figure 4. Double immunostaining with anti-GFP and anti-calsenilin antibodies. A-C, Co-staining of GFP in 
A and calsenilin in B viewed in retinal whole-mount. The superimposition of A and B in C. D-F, Co-staining 
of GFP in D and calsenilin in E viewed in retinal vertical section. The superimposition of D and E in F. Scale 
bars: 25 μm. 
 
Figure 5. The age-dependent expression of GFP in retinal BCs. The expression of GFP viewed in retinal 
whole-mounts and vertical sections at the ages of postnatal A day 5, B 7, C 11, D two weeks, E one month, 
and F 6 months. Scale bars: 25 μm.  
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Table 4. Comparison of Calsenilin-positive and negative CBCs at the ages of 1 and 6 months. The cell 
numbers are the average of eight 40X pictures (0.0037 mm2 per image; four images are taken from central 
portion of the retina and the other four are taken from peripheral areas; n = 12 retinas for 1 month; n = 10 
retinas for 6 months)  
DISCUSSIONS 
This study revealed GFP labeled BCs in a 5-HTR2a transgenic mouse line. Our results 
show that the majority of the GFP labeled BCs are type 4 CBCs. This is based both on their 
terminal stratification pattern and immunostaining. First, the axon terminals of the strongly GFP 
labeled BCs were found to ramify in sublamina 1 and 2 of the IPL. Based on the classification of 
BCs in rodents, type 1-4 BCs have been described to have their axon terminals ramifying in 
sublamina 1 and/or 2 (Ghosh et al., 2004). However, among them, only type 4 CBCs have their 
axon terminals ramifying in both sublamina 1 and 2. Second, the GFP labeled cells were 
immunoreactive to anti-calsenilin antibody, an antibody that has been shown to stain type 4 
CBCs in the mouse retina (Haverkamp et al., 2008). Furthermore, the GFP labeled BCs were 
found to be negative to antibodies against recoverin and Syt-2. Both of these antibodies label 
type 2 CBCs in the mice. In addition, the GFP labeled BCs were not found to co-localize with 
HCN4-positive cells and PKARIIβ positive cells, with the exception of a few cells for the latter. 
HCN4 and PKARIIβ antibodies have been reported to label two subtypes of type 3 CBCs 
(Mataruga et al., 2007). The reason for the localization of very few GFP labeled cells and 
PKARIIβ positive cells is not clear. It might be possible that very few GFP labeled BCs were 
type 3 CBCs or the anti-PKARIIβ antibody could occasionally label type 4 CBCs.  
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In addition, we found that the axon terminals of a small portion of GFP labeled BCs, 
albeit weakly labeled, ramified in sublamina 4 and 5. Because the diffuse nature of their axon 
terminals in the proximal portion of the IPL, they are unlikely to be type 7 CBCs which are 
restricted their axon terminal stratification restricted to sublamina 4 (Huang et al., 2003) or RBCs 
which have their axon terminals stratifying in sublamina 5, close to the ganglion cell layer. Also, 
since neither the GFP labeled BC somas nor the weakly labeled axon terminals were stained by 
an anti Syt-2 antibody which stains type 2 and 6 CBCs, the CBCs with their weakly labeled axon 
terminals in the proximal portion of the IPL cannot be type 6 CBCs. Taken together, our results 
suggest that the weakly labeled axon terminals likely belong to type 8 or 9 CBCs. Unfortunately, 
currently no antibodies are available that can label type 8 or 9 CBCs.  
The expression of GFP in CBCs in this transgenic mouse were observed as early as 
postnatal day 5 and the expression is stable at least up to the age of 6 months. The cell densities 
for both the calsenilin positive and negative CBCs at the age of 1 and 6 months were not found 
to be significantly changed. The value for the calsenilin positive cells is ~3600/mm2, which is 
slightly higher than the value of ~3,000/mm2 in type 4 CBCs reported by a recent study (Wassle 
et al., 2009). The discrepancy could be due to different mouse strains used in these studies 
(FVB/N-Swiss vs. C57BL/6J).  The cell density for calsenilin negative cells is ~1,500/mm2. The 
cell density of the type 9 CBCs was reported to be around 600/mm2. So far, the cell density of 
the type 8 CBCs remains unknown.  
It is worth to point out that since the mouse strain used in this study carries an rd1 (or 
Pde6brd1) gene, the un-altered cell density observed for both types of GFP labeled BCs between 
the ages of one month and 6 month suggests that retinal remodeling did not cause significant cell 
death of these CBCs in this rd1 mouse strain up to 6 months of age. However, a dramatic 
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morphological remodeling of second order cells after the death of photoreceptors has been 
previously reported (Strettoi and Pignatelli, 2000). Thus, it would be interesting to examine how 
the retinal degeneration affects the synaptic circuits. The transgenic mouse line with GFP labeled 
BCs could be used for such a purpose. 
So far, whether mammalian retinas express 5-HTR2a immunoactivity remains unclear. 
An early study reported 5-HTR2a immunoactivity in the retinas of rabbit (Pootanakit et al., 
1999). The staining was found to be in photoreceptor terminals and RBCs. Using two different 
anti-5-HTR2a antibodies, a recent study showed the 5-HTR2a immunoactivity in glia cells and 
some amacrine cells in the bullfrog retina but not in the rat retina (Han et al., 2007). Since the 
antibody used by Pootanakit and colleague (1999) was the only one that has been reported to 
show immunoactivity in the mammalian retina so far, we examine the expression pattern of this 
same antibody in this 5-HTR2a transgenic mouse line. Interestingly, our results show this 
antibody stained a certain population of CBCs, but these BCs were not found to co-localize with 
the GFP labeled CBCs. It remains unknown whether the discrepancy of the 5-HTR2a 
immunoactivity and the GFP expression is due to a non-specificity of this 5-HTR2a receptor 
antibody in the mouse retina or the non-specificity of the GFP targeting of this transgenic mouse 
line, or both. Nevertheless, the targeting expression of GFP to the specific CBCs in this 
transgenic mouse line will be a useful tool for retinal research.  
Transgenic mouse lines expressing GFP in RBCs (Morgans et al., 2006; Dhingra et al., 
2008), and type 5, 7, and 9 CBCs (Wong et al., 1999; Huang et al., 2003; Haverkamp et al., 2005; 
Haverkamp et al., 2009; Wassle et al., 2009) have been previously reported. These BC specific 
GFP transgenic mouse lines have been used in the study of BC development (Morgans et al., 
2006), synaptic circuits (Han and Massey, 2005; Lin et al., 2005; Wassle et al., 2009), 
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physiological properties (Duebel et al., 2006) and molecular biology (Huang et al., 2003; 
Dhingra et al., 2008). The revelation of GFP expression in type 4 CBCs and possibly also type 8 
or 9 CBCs in this transgenic line expended further this valuable tool to include these CBCs. In 
particular, the expression of GFP in type 4 BC bodies is sufficiently bright without the 
enhancement of antibody. Therefore, this mouse line can be used for in vitro electrophysiological 
recordings of type 4 CBCs in retinal slices or dissociated preparations. It should be noted that 
although the type 4 CBCs in the mouse can be stained by anti-calsenilin antibody (Haverkamp et 
al., 2008), this antibody also labels the processes of third order neurons in the IPL, which 
excludes the use of this antibody to label the axon terminals of this BC type. Therefore, this 
mouse line will also be useful for examining the synaptic circuits of type 4 CBCs with retinal 
third order neurons. Furthermore, as shown in this study, the expression of GFP in BCs was 
detected in early postnatal retinas as well as in aged retinas. Therefore, this transgenic mouse line 
could be used to study the development and aging of retinal BCs. Finally, crossing this mouse 
with wild-type and other transgenic lines with retinal diseases will allow the study of effects on 
retinal BCs during disease processes.  
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CHAPTER 3 Cre-mediated recombination efficiency and 
transgene expression patterns of three retinal bipolar cell-
expressing Cre transgenic mouse lines 
SUMMARY 
Retinal bipolar cells play an essential role in segregating visual information into multiple 
parallel pathways in the retina. The ability to manipulate gene expression in specific BC type (s) 
in the retina is important for understanding the molecular basis of their normal physiological 
functions and diseases/disorders. The Cre/LoxP recombination system has become an important 
tool for allowing gene manipulation in vivo, especially with the increasing availability of cell- 
and tissue-specific Cre transgenic mouse lines. Detailed in vivo examination of the Cre/LoxP 
recombination efficiency and the transgene expression patterns for cell- and tissue-specific Cre 
transgenic mouse lines is essential for evaluating their utility. In this study, we investigated the 
Cre-mediated recombination efficiency and transgene expression patterns of retinal BC-
expressing Cre transgenic mouse lines by crossing them with a Cre reporter mouse and through 
Cre-dependent recombinant adeno-associated virus (rAAV) vector-mediated transgene delivery. 
INTRODUCTION 
Retinal BCs, the second-order neurons with multiple types in the retina, transmit visual 
information from photoreceptors to third-order retinal neurons and segregate visual information 
into multiple parallel pathways in the retina (Wassle, 2004). BCs are subdivided into ON- and 
OFF-types, based on their light- response polarity, and into rod and CBCs, based on their 
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synaptic inputs. In mammals, a single type of RBC (Dowling and Boycott, 1969; Dacheux and 
Raviola, 1986) and about nine types of CBCs have been characterized based on their terminal 
stratification in the inner plexiform layer (IPL) and cell-type-specific molecular markers 
(Famiglietti, 1981; Kolb et al., 1981; Pourcho and Goebel, 1987; Euler and Wassle, 1995; Ghosh 
et al., 2004; Pignatelli and Strettoi, 2004; Wassle et al., 2009; Light et al., 2012). BCs of 
different types are known to exhibit diverse physiological properties (Awatramani and Slaughter, 
2000; DeVries, 2000; Euler and Masland, 2000; Wu et al., 2000); however, less is known about 
the molecular basis of this diversity.  
Gene manipulation in specific BC types in the retina offer an approach to investigate BC 
physiological and pathological properties. In addition, BC diseases animal models can be 
generated for further gene therapy. The Cre/LoxP recombination system has become a powerful 
tool for allowing gene manipulation in vivo (Nagy, 2000; Branda and Dymecki, 2004), especially 
with the increasing availability of cell- and tissue-specific Cre transgenic mouse lines 
(Gaveriaux-Ruff and Kieffer, 2007; Gong et al., 2007). A widely used conditional gene-targeting 
approach is to cross cell- and tissue-specific Cre transgenic mouse lines with Cre-dependent 
reporter or conditional mouse lines. Cre transgenic lines, especially those produced by 
conventional methods (via pronuclear injection), are subject to the local chromatin environment 
(i.e., position effect), which could lead to transgene silencing or variable ectopic expression 
(Milot et al., 1996; Williams et al., 2008; Le, 2011; Smith, 2011). Detailed in vivo examination 
of the expression pattern and recombination efficiency of Cre-mediated reporter gene expression 
in targeted tissues is essential for evaluating their utility. Cre-dependent virus-mediated gene 
delivery is another powerful approach that can be used to target a transgene to Cre-expressing 
cells in transgenic mouse lines (Schnutgen et al., 2003; Atasoy et al., 2008; Kuhlman and Huang, 
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2008). Recombinant adeno-associated virus (rAAV) vectors have been particularly widely used 
in retinal gene transfer (Surace and Auricchio, 2008). Due to their anatomical location in the 
middle of the retina, however, retinal BCs are the most inaccessible cell types in the retina to 
virus transduction. The feasibility of the Cre-dependent rAAV vector-mediated transgene 
delivery to retinal BCs in Cre transgenic mouse lines has not been examined. 
So far, only a small number of retinal BC-expressing Cre transgenic mouse lines have 
been reported (Barski et al., 2000; Rowan and Cepko, 2004; Saito et al., 2005; Zhang et al., 2005; 
Ivanova et al., 2010; Nickerson et al., 2011). Most of them were driven by the Pcp2 (Purkinje 
cell protein 2) promoter, a gene that is known to target Purkinje cells in the cerebellum as well as 
retinal RBCs (Oberdick et al., 1990). Few Cre transgenic lines have been reported to target 
retinal CBCs. One of them is Chx10-cre, which was reported to target the Cre recombinase in 
multiple retinal BC types (Rowan and Cepko, 2004).  
In this study, we examined the Cre-mediated recombination expression profiles of three 
retinal BC-expressing Cre-transgenic lines, 5-HTR2a-cre, Pcp2-cre, and Chx10-cre, by crossing 
these lines to a strong Cre reporter mouse line. We characterized the Cre-mediated expression 
patterns in multiple BC types in the 5-HTR2a-cre and Pcp2-cre mouse lines. We also examined 
the ability and transduction efficiency of Cre-dependent rAAV-mediated transgene delivery to 
BCs of the BC-expressing transgenic lines. We found that a Cre-dependent rAAV2/2 vector 
using cytomegalovirus (CMV) promoter and containing a capsid mutation of Y444F is capable 
of achieving Cre-mediated transgene expression in retinal BCs.  
METHODS 
Animals 
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All animal handling procedures were approved by the Institutional Animal Care and Use 
Committee at Wayne State University and were in accordance with the NIH Guide for the Care 
and Use of Laboratory Animals. Three Cre transgenic lines were used in this study: (1) 
Tg(Htr2a-cre)KM207Gsat/Mmcd (referred to as 5-HTR2a-cre), produced by the expression of 
Cre under the control of the BAC 5-hydroxytryptamine (serotonin) receptor 2A promoter (Gong 
et al., 2003; Gong et al., 2007); (2) Tg (Pcp2-cre)1Amc/J (referred to as Pcp2-cre), generated by 
driving Cre recombinase and GFP under the control of a modified mouse Pcp2 (Purkinje cell 
protein 2) promoter enhancer (Lewis et al., 2004); (3) Tg (Chx10-EGFP/cre-ALPP)2Clc/J 
(referred to as Chx10-cre), produced by the expression of a green fluorescent protein (GFP)/Cre 
fusion transgene under the control of a BAC clone containing the mouse transcription factor 
Chx10 (C. elegans ceh-10 homeodomain-containing homolog) promoter (Rowan and Cepko, 
2004). The 5-HTR2a-cre line was chosen because a previous study showed that a 5-HTR2a-GFP 
line produced by the expression of GFP under the control of the same BAC 5-HTR2a promoter 
predominantly expressed GFP in type 4 CBCs (Lu et al., 2009). The transgenes of both Pcp2-cre 
and Chx10 mouse lines contain GFP, but the GFP fluorescence signal is relatively weak 
(Ivanova et al., 2010). These mice were crossed with a strong Cre reporter line, B6.Cg-
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J (referred to as tdTomato reporter line), which 
harbors a combination of the CMV early enhancer element and chicken beta-actin (CAG) 
promoter-driven red fluorescent protein (RFP) variant, tdTomato, at the Gt (ROSA)26Sor locus 
with a loxP-flanked STOP sequence (Madisen et al., 2010). When bred to mice with a Cre 
recombinase gene under the control of a promoter of interest, the STOP sequence is deleted in 
Cre-expressing cells, and tdTomato is expressed. The 5-HT2a-cre mice were purchased from 
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Mutant Mouse Regional Resource Center (MMRRC; University of California, Davis, CA, USA); 
all other mice were purchased from Jackson Laboratory (Bar Harbor, ME, USA).  
AAV virus construct and virus injection 
The construct that conferred the rAAV2-mediated expression of a double-floxed inverted 
open-reading frame (DIO) encoding channelrhodopsin-2-mCherry (ChR2-mCherry) with a 
ubiquitous neuronal promoter Elongation factor I alpha (EF1α), rAAV2-EF1α-DIO-ChR2-
mCherry, was kindly provided by Karl Deiserroth at Stanford University. The construct of 
rAAV2-CMV-DIO-ChR2-mCherry was made by replacing EF1α with the ubiquitous viral 
promoter, CMV. Virus vectors of rAAV2-EF1α-DIO-ChR2-mCherry were produced in normal 
rAAV2, and virus vectors of rAAV2-CMV-DIO-ChR2-mCherry were made in Y444F capsid 
mutation at the virus core facility of University of Pennsylvania. Virus vectors were injected 
intravitreally into the eyes of Cre-transgenic mouse lines, as previously described (Ivanova et al., 
2010). Briefly, one- to two-month-old mice were anesthetized by intraperitoneal injection of a 
mixture of 120 mg/kg ketamine and 15 mg/kg xylazine. Under a dissecting microscope, a small 
perforation was made in the temporal sclera region with a needle. A total of 1.5 μl of viral vector 
suspension in saline at a concentration of 1.3 x 1012 GC/ml and 5.6 x 1012 GC/ml for rAAV2 
(Y444F)-CMV-DIO-ChR2-mCherry and rAAV2-EF1α-DIO-ChR2-mCherry, respectively, was 
injected into the intravitreal space through the perforation with a Hamilton syringe. The 
expression of ChR2-mCherry was examined one month after the injection. 
Immunohistochemical staining  
Mice were deeply anesthetized with CO2 and decapitated. The retinas were fixed in the 
eyecups with 4% paraformaldehyde in 0.1 M phosphate buffer (PB, pH7.4) for 20 min. For 
retinal whole-mounts, the fixed retina was dissected free in PB solution, flat-mounted on slides, 
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and coverslipped. For retinal vertical sections, the retinas were cryoprotected in a sucrose 
gradient (10%, 20%, and 30% w/v in PB), and cryostat sections were cut at 14 μm. 
The expression of tdTomato fluorescence in the retina was examined in retinal whole-
mounts and/or vertical sections. For retinal vertical section imaging, tdTomato fluorescence was 
sufficient to visualize the tdTomato signal. Therefore, the tdTomato fluorescence was not 
enhanced with an antibody. For retinal whole-mount imaging, to stabilize the fluorescence signal 
and reduce bleaching, the tdTomato fluorescence was enhanced using an anti-mCherry antibody, 
which recognizes tdTomato, followed by a secondary antibody conjugated to Alexa 555 or Alexa 
594.  
For immunostaining, retinal whole-mounts or vertical sections were blocked for 1 h in a 
solution containing 5% Chemiblocker (membrane-blocking agent; Chemicon, Brica, MA, USA), 
0.5% Triton X-100 and 0.05% sodium azide (Sigma). The primary antibodies were diluted in the 
same solution and applied overnight, followed by incubation (1 h) in the secondary antibodies, 
which were conjugated to Alexa 594 (1:600, red fluorescence, Molecular Probes), Alexa 555 
(1:600, red fluorescence, Molecular Probes), Alexa 488 (1:600, green fluorescence, Molecular 
Probes), or AMCA (1:200, blue fluorescence). The following antibodies were used in this study: 
rabbit anti-mCherry (1:500, 632496, Clontech); mouse anti-calsenilin (1:2,000; kindly provided 
by W. Wasco, Harvard Medical School, Boston, MA, USA); rabbit anti-PKC (1:20,000, catalog 
number 2056, Cell Signal); mouse anti-PKC (1:10000, catalog number sc8393, Santa Cruz); 
mouse anti–synaptotagmin II (Syt-2; 1:600; Zebrafish International Resource Center, Eugene, 
OR); rabbit anti-HCN4 (1:500; Alomone Labs); mouse anti–protein kinase A (PKA) RIIβ 
(1:80,000; BD Biosciences).  
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All steps were carried out at room temperature (RT). All images were made using a Zeiss 
Axioplan 2 microscope with the Apotome oscillating grating to reduce out-of-focus stray light. 
Most images were acquired at an approximate optical thickness of 0.4 µm for vertical sections 
and 0.7 µm for whole-mount tissues. Z-stack images (0.5 μm step size, 20 to 30 sections) were 
captured and displayed as maximum intensity projections. The full image size is 1388 x 1040 
pixels. The excitation light source is mercury short-arc HXP 120. The following filter sets 
(excitation, dichroic mirror, and emission) were used: Alexa 555 or 594 (BP 546/12, FT 580, LP 
590); Alexa 488 (BP 470/40, FT 510, and BP 540/50); AMCA (labeling, BP 365/12, FT 395, LP 
397). Brightness and contrast of the final images were adjusted using Adobe Photoshop CS4 to 
enhance visibility.  
RESULTS 
Three retinal BC-expressing Cre transgenic lines, 5-HTR2a-cre, Pcp2-cre, Chx10-cre, 
were crossed with a strong Cre-dependent reporter line that expresses a RFP variant, tdTomato 
for examining the Cre-medicated recombination pattern in the retina and, especially in BCs. The 
expression of tdTomato fluorescence in the retina was examined in retinal vertical sections 
without antibody enhancement, and in retinal whole-mounts with antibody enhancement (see 
Methods). 
5HTR2a-cre mouse line 
For the 5HTR2a-cre line, in retinal whole mounts, bright tdTomato-expressing cells were 
observed throughout the retina, especially in the focal plane at the distal portion of the inner 
nuclear layer (INL) (Fig. 6A). In retinal vertical sections, the majority of these cells appeared to 
be BCs, with their somas located in the distal portion of the INL (Fig. 6B). The tdTomato-
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labeled cell processes were observed through the entire inner plexiform layer (IPL), although the 
fluorescence signal was more intense in the distal half of the IPL. In addition, some sparse axon 
terminals located in the proximal portion of the IPL were also apparent (marked by arrows in Fig. 
6B). These terminals resemble the axon terminals of RBCs with their characteristic terminal 
buttons and their location in the proximal margin of the IPL. Furthermore, tdTomato-expressing 
cells with their somas located in the proximal portion of the INL and ganglion cell layer were 
also observed (Fig. 6B). These cells were most likely ganglion cells or displaced amacrine cells 
(Perez De Sevilla Muller et al., 2007).  
 
 
Fig. 6. tdTomato-expressing cells in the 5-HTR2a-cre transgenic mouse line. A, tdTomato-expressing cells 
viewed in a retinal whole-mount with the focal plane at the distal portion of the INL. B, tdTomato-expressing 
cells viewed in a retinal vertical section. The arrowhead points to the BCs with their axon terminals located 
in the proximal portion of the IPL. ONL, outer nuclear layer; INL, inner nuclear layer; IPL, inner plexiform 
layer; GCL, ganglion cell layer. Scale bar 50 µm in A (applies to B). 
To identify the BC types in the 5-HTR2a-cre line, we co-labeled tdTomato-expressing 
cells with several BC type-specific antibodies. Our previous studies showed that the GFP-
expressing cells in a 5-HT2aR-GFP transgenic animal line are predominantly type 4 BCs (Lu et 
al., 2009). Therefore, we first labeled the retina with an antibody to calsenilin, a type 4 BC 
marker (Haverkamp et al., 2008). Indeed, in retinal vertical sections, the majority of the 
tdTomato-expressing cells were found to be immunoreactive for calsenilin (Fig. 7A-C; marked 
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by stars at the somas). The labeling with calsenilin in the majority of the tdTomato-expressing 
BCs was also observed in retinal whole mounts with the focal plane at the distal portion of the 
INL (Fig. 7D-F), but there were also a small number of tdTomato-expressing cells that were 
negative for calsenilin staining (marked by arrows). In retinal whole mounts, approximately 69.5 
± 8.9% (Mean ± SEM; n = 6 retinas) of the tdTomato-expressing cells that were located in the 
distal portion of the INL were immunoreactive for calsenilin. Next, we labeled the retina with an 
antibody against PKCα, a RBC marker. In retinal vertical sections, some tdTomato-expressing 
cells (4.5 ± 2.5%; n = 6 retinas) were found to be immunoreactive for PKCα (Fig. 7G-I; marked 
by arrows at the somas and arrowheads at the terminals). Furthermore, we labeled tdTomato-
expressing cells with other bipolar-cell-specific markers. We found that a small number of the 
tdTomato-expressing cells were immunoreactive for PKAIIβ (Fig. 7J-L; marked by stars at the 
somas) but none were immunoreactive for HCN4 (Fig. 7M-O). HCN4 and PKAIIβ antibodies 
are known to label type 3a and type 3b CBCs, respectively (Mataruga et al., 2007). In addition, 
the tdTomato-expressing cells were not found to be labeled with synaptotagmin2 (Syt-2) (Fig. 
7P-R), an antibody that labels both type 2 and type 6 CBCs (Fox and Sanes, 2007; Wassle et al., 
2009).  
Taken together, these results indicate that the majority of the tdTomato-expressing BCs 
in the 5-HTR2a-cre line are type 4 CBCs. In addition, the tdTomato-expressing cell population 
includes RBCs and type 3b CBCs (see Table 1). 
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Figure 7. Immunolabeling of the tdTomato-expressing retinal BCs in the 5-HTR2a-cre mouse line with BC-
type specific antibodies. A-C, in a retinal vertical section, the tdTomato-expressing retina A was 
immunostained for calsenilin in B. The overlay of A and B is shown in C. The double-positive BCs are 
marked with stars. D-F, in a retinal whole mount with the focal plane at the distal portion of the INL, the 
tdTomato-expressing retina D was immunostained for calsenilin in E. The overlay of D and E is shown in F. 
G-I, the majority of the tomato-expressing cells in the distal portion of the INL are calsenilin-positive. The 
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tdTomato-expressing cells that do not show calsenilin staining are marked with arrowheads. The tdTomato-
expressing retina was immunostained for PKCα in a retinal vertical section. The double-positive BCs are 
marked with arrows in the somas and arrowheads pointing to the axon terminals. J-L, The tdTomato-
expressing retina was immunostained for PKARIIβ. Two double-positive cells are marked with stars. M-R, 
the tdTomato-expressing retinal BCs were not found to be labeled by antibodies for HCN4 in M-O and Syt-
2 in P-R. Scale bars 50 µm. 
Pcp2-cre mouse line 
For the Pcp2-cre line, bright tdTomato-expressing cells were also observed throughout 
the retina. When examined in retinal vertical sections, the vast majority of the tdTomato-
expressing cells were located in the INL, which were clearly all BCs based on their characteristic 
morphology (Fig. 8A). As shown in Figure 8A, the tdTomato-expressing BCs tend to form 
clusters. Some of the cells appeared to be RBCs based on their characteristic terminal buttons 
located in the proximal margin of the IPL (Fig. 8B; marked by white arrowheads). In addition, 
BCs with axon terminal stratification in the distal portion of the IPL (sublaminae 1 and 2; 
marked by yellow arrowheads) as well as in the proximal portion of the IPL (sublaminae 4 and 5; 
marked by blue arrowheads) were also observed, suggesting the presence of labeling in both ON 
and OFF CBCs. In retinal whole-mount, the tdTomato-expressing BC somas and axon terminals 
can also be visualized with the focal plane at the distal portion of the INL (Fig. 8C) and the 
proximal portion of the IPL to the ganglion cell layer (GCL) (Fig. 8D), respectively. In addition, 
sparsely distributed cells with their somas located in the ganglion cell layer were also labeled 
(marked by an arrowhead in Fig. 8D). The characterization of these ganglion cells has been 
reported (Ivanova, 2012 ). 
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Figure 8. tdTomato-expressing cells in the Pcp2-cre transgenic mouse line. A, tdTomato-expressing cells 
viewed in a retinal vertical section. B, representative BCs in high magnification viewed in retinal vertical 
sections. The IPL was divided into 5 sublaminae. White arrowheads point to the axon terminals of RBCs. 
Yellow arrowheads point to the axon terminals of BCs stratified in the distal portion of IPL. Blue arrowheads 
point to the axon terminals of BCs stratified in the proximal portion of IPL. C, tdTomato-expressing cells 
viewed in a retinal whole-mount with the focal plane at the INL. D, whole-mount view of the axon terminals 
of the tdTomato-expressing BCs with the focal plane at the proximal portion of the IPL to ganglion cell layer. 
The arrowhead points to a weak tdTomato-expressing ganglion cell. The images in C and D were taken in 
the same field. Scale bars 25 µm in A, C, and D and 10 µm in B. 
 
Table 5. The summary of bipolar cell types identified in 5-HTR2a-cre and Pcpc2-cre mouse lines. The 
percentage value for each bipolar cell type was estimated based on the total tdTomato- expressing cells in 
the distal portion of the inner nuclear layer. Unexamined bipolar cell types are marked with “-.” 
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Figure 9. 
Immunolabeling of the 
tdTomato-expressing 
retinal BCs in the Pcp2-
cre mouse line with 
bipolar-cell-type specific 
antibodies. A-C, in 
retinal vertical sections, 
the tdTomato-
expressing retina was 
immunostained for 
PKCα in B. The overlay 
of A and B is shown in 
C. The double-positive 
BCs were marked with 
stars in the somas and 
with arrowheads 
pointing at the axon 
terminals. D-F, in retinal 
whole-mount with the 
focal plane in the INL, 
co-labeling with 
tdTomato and PKCα. 
PKCα-negative 
tdTomato-expressing 
cells are marked with 
arrows. G-I, The 
tdTomato-expressing 
retina was 
immunostained for Syt-
2. The double-positive 
BCs with axon terminals 
stratified at the distal 
portion of the IPL (type 
2 CBCs) are marked 
with white stars in the 
somas and with white 
arrowheads pointing at 
the axon terminals. The 
double-positive BCs 
with axon terminals stratified in the proximal portion of the IPL (type 6 CBCs) are marked with yellow 
arrows at the somas and yellow arrowheads at the axon terminals. A tdTomato-expressing BC with their 
axon terminals stratified slightly distal to Syt2-positive cells is marked with a blue arrowhead in I. J-O, the 
tdTomato-expressing retinal BCs were not found to be labeled by PKARIIβ in J-L, HCN4 in M-O, and 
calsenilin in P-R. Scale bars 50 µm. 
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Figure 10. tdTomato-expressing pattern in the Chx10-cre transgenic mouse line. A-C, In a retinal vertical 
section, the expression pattern of tdTomato fluorescence is compared with that of GFP-cre. The GFP was 
enhanced with an antibody to GFP. The overlay of A and B is shown in C. D-F, In the same retinal vertical 
section, the expression pattern of PKC in D, which labels RBCs, is compared with that of GFP and 
tdTomato. The overlay of PKC and GFP labeling is show in E.  The triple overlay of PKC, GFP, and 
tdTomato labeling is show in F. Scale bars 25 µm. 
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Figure 11. Cre-dependent rAAV-
mediated transgene delivery to retinal 
BCs. A-B, The Cre-dependent rAAV2 
virus vector cassettes that mediate the 
expression of a double-floxed inverted 
open-reading frame (DIO) encoding 
channelrhodopsin-2-mCherry (ChR2-
mCherry) with ubiquitous neuronal 
promoter EF1α in A and with Y444F 
capsid mutation and a ubiquitous viral 
promoter, cytomegalovirus (CMV) in B. 
WPRE: woodchuck post-transcriptional 
regulatory element. hGHpA: a human 
growth hormone polyadenylation 
sequence. C-D, The expression of 
ChR2-mCherry mediated by virus 
vectors with the vector cassette shown 
in A in Pcp2-cre mice, viewed in retinal 
vertical section in C and in retinal whole 
mount with the focal plane at the GCL in 
D. E-F, The expression of ChR2-
mCherry mediated by virus vectors with 
the vector cassette shown in B in Pcp2-
cre mice, viewed in retinal vertical 
section in E and in retinal whole mount 
with the focal plane at the INL in F. G-I, 
The expression of ChR2-mCherry 
infected by virus vectors with the vector 
cassette shown in B in Chx10-cre mice, 
viewed in retinal vertical section in G-H 
and in retinal whole mount with the focal 
plane at the INL in I. J-L, in vertical 
retinal sections, co-labeling of GFP in J 
and mCherry in K of the virus infected 
retina in Chx10-cre mice. The overlay of 
J and K is shown in L. The double-
positive BCs were marked with 
arrowheads. Scale bars 25 µm in C, E, 
G, H, and J-L and 100 µm in D, F, and I. 
To identify the BC types in the Pcp2-cre line, we co-labeled the tdTomato-expressing 
cells with the BC-specific antibodies. First, many tdTomato-expressing cells were labeled with 
PKCα and, therefore, are RBCs as revealed in retinal vertical sections (Fig. 9A-C; marked by 
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stars in the somas and arrowheads at the axon terminals). The co-labeling of PKCα and 
tdTomato was also observed in retinal whole mounts (Fig. 9D-F). Approximately 75.5 ± 7.1% 
(Mean ± SEM; n = 6) of the tdTomato-expressing BCs were immunoreactive for PKCα, 
indicating that the majority of the tdTomato-expressing cells were RBCs, but the presence of 
PKCα negative tdTomato-expressing cells is also evident (marked by arrows in Fig. 9D-F). 
These results suggest that other BC types exist in addition to RBCs. Indeed, some tdTomato-
expressing cells were immunoreactive for Syt2 (Fig. 9G-I). Among them, a few of these cells 
had their axon terminals stratified in the distal portion of the IPL (somas marked by white starts 
and axon terminals identified by white arrowheads) and, therefore, were most likely type 2 CBCs. 
The majority of the Syt2-positive cells had their axon terminals stratified in the proximal portion 
of the IPL (somas marked by yellow arrows and axon terminals marked by yellow arrowheads) 
and thus should be type 6 BCs. The percentage of these two cell types was not determined due to 
a weak labeling of Syt2 at the somas. On the other hand, the tdTomato-expressing cells were not 
labeled by antibodies against PKAIIβ (Fig. 9J-L), HCN4 (Fig. 9M-O), or calsenilin (Fig. 9P-R), 
indicating that there were no type 3 and type 4 tdTomato-expressing BCs. In addition, there were 
tdTomato-expressing BCs with axon terminals stratified slightly distal to Syt2-positive type 6 
BCs (marked by a blue arrowhead in Fig. 9I). These cells might be type 5 and/or 7 CBCs.  
Taken together, these results indicate that the majority of the tdTomato-expressing cells 
in the Pcp2-cre line are RBCs. The tdTomato-expressing cells also contain numerous type 6 
CBCs, some type 2 CBCs, and possibly also type 5 or 7 CBCs, but not type 3 or 4 CBCs (see 
Table 5). 
Chx10-cre mouse line 
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For the Chx10-cre line, very bright tdTomato fluorescence was observed through the 
entire retina in retinal whole-mount preparations (data not shown). In vertical sections, the 
tdTomato fluorescence was predominantly located in Müller cells, based on their characteristic 
morphology (Fig. 10A). Interestingly, this pattern does not fully resemble that of the GFP-cre 
(enhanced with GFP antibody) (Fig. 10B-C). In particular, the tdTomato fluorescence was absent 
in the strongest GFP-labeled cells, with their somas located in the distal portion of the INL and 
their axon terminals located in the proximal margin of the IPL. These strongest GFP-labeled 
cells were RBCs because they showed co-labeling with an antibody against PKC (Fig. 10D-F). 
The GFP-labeled cells including weakly labeled Müller cells were visible without antibody 
enhancement. Also, previous studies showed that the Cre and GFP immunostaining patterns are 
the same (Ivanova et al., 2010). The latter would be expected because the transgenic line was 
generated with a GFP-Cre fusion transgene (Rowan and Cepko, 2004). Therefore, the bright 
expression of tdTomato fluorescence in the Müller cells could be explained by a low level of Cre 
expression in these cells. The lack of tdTomato fluorescence in the strong GFP-Cre-expressing 
BCs, however, is unexpected. The examination of retinal BC types in this line, therefore, was not 
further performed. 
Cre-dependent rAAV-mediated transgene delivery 
We next evaluated the ability and efficiency of Cre-dependent rAAV-mediated gene 
delivery for targeting the transgene to Cre-expressing BCs in the retina. We first examined a 
rAAV2 vector construct carrying a double-floxed inverted open-reading frame (DIO) sequence 
encoding channelrhodopsin-2-mCherry (ChR2-mCherry) driven by a ubiquitous neuronal 
promoter, EFlα (see Fig. 11A). The viral vectors were injected intravitreally in the eyes of adult 
Pcp2-cre mice. This virus vector construct was found to be able to effectively deliver the 
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transgene to retinal ganglion cells but not BCs. As shown in retinal vertical sections (Fig. 11C), 
bright expression of ChR2-mCherry was observed in a population of Cre-expressing retinal 
ganglion cells, but its expression was barely detectable in retinal BCs. The bright expression of 
ChR2-mCherry in retinal ganglion cells was also evident in retinal whole mount with the focal 
plane at the GCL (Fig. 11D). Because a recent study reported that a capsid mutation of AAV2 
(Y444F) can markedly increase the transduction efficacy in distal retinal neurons via intravitreal 
injection (Petrs-Silva et al., 2009), we replaced the virus construct with the capsid mutation. In 
addition, the EFlα promoter was replaced with a ubiquitous viral promoter, CMV (Fig. 11B), 
because rAAV2 vectors with CMV promoters were observed to show a better transduction 
efficacy in BCs (unpublished observations). Indeed, the virus vector with the combination of the 
Y444F capsid mutation and the CMV promoter resulted in bright expression of ChR2-mCherry 
in retinal BCs as well as in retinal ganglion cells (Fig. 11E). The expression of ChR2-mCherry in 
retinal BCs was also shown in retinal whole-mount with the focal plane at the INL (Fig. 11F). 
We also examined the Cre recombination profile of the rAAV2 vectors with the 
combination of the Y444F capsid mutation and the CMV promoter in the Chx10-cre mouse line 
because of its unexpected Cre recombination profile with the reporter mouse line. The expression 
of ChR2-mCherry was observed in many BCs, as shown in retinal vertical sections (Fig. 11G 
and H), and in the retinal whole-mount, with the focal plane at the INL (Fig. 11I). Based on their 
morphological properties and terminal stratification, both RBCs (marked by yellow arrowheads 
in Fig. 11G and H) and CBCs (marked by a white arrowhead in Fig. 11H) were transfected, 
consistent with the expression of Cre in the multiple BC types reported in this line (Rowan and 
Cepko, 2004). In addition, the expression of ChR2-mCherry was also observed in some Müller 
cells (marked by a blue arrowhead in Fig. 11G). Furthermore, we performed the co-labeling of 
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GFP-cre and mCherry (Fig. 11J-L). The results confirm that mCherry indeed targeted to GFP-cre 
expressing BCs (marked by arrowheads). 
DISCUSSION 
In this study, we examined the Cre/LoxP recombination efficiency and expression 
patterns of three retinal BC-expressing Cre transgenic lines by crossing these lines with a strong 
Cre reporter line. We also examined the Cre-dependent rAAV-mediated gene delivery and 
reported a rAAV vector construct that is capable of delivering the transgene to BCs through 
intravitreal injection. 
Our results show that, for the 5-HTR2a-cre and Pcp2-cre mouse lines, the expression 
pattern of the transgene in BCs mediated by the Cre recombination through the reporter line 
largely resembles the expression pattern of Cre. However, for both lines, this study revealed 
additional BC types that are involved in Cre recombination, as discussed below. For the 5-
HTR2a-cre mouse line, our results show that the majority of the tdTomato-expressing BCs 
observed after crossing with the reporter line are type 4 CBCs, based on the co-labeling with 
antibodies against calsenilin. This result is similar to the previous reported result of a 5-HTR2a-
GFP mouse line that was produced using the same BAC promoter construct (Lu et al., 2009). In 
addition, in both 5-HTR2a-cre and 5-HTR2a-GFP lines, a few of the labeled BCs were identified 
to be type 3b CBCs. Two discrepancies, however, were observed between the tdTomato 
expression pattern in the 5-HTR2a-cre line and the GFP expression pattern of 5-HTR2a-GFP. 
First, a small percentage of the tdTomato-expressing cells in the 5-HTR2a-cre line were 
observed to be RBCs. In addition, many bright tdTomato-expressing third-order neurons were 
observed in this line. These differences are likely to result from the combination of the highly 
sensitive Cre recombination and the strong Cre reporter line used in this study. In previous 
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studies of the 5-HTR2a-GFP line, barely visible GFP (after GFP enhancement) was observed in 
some ON type CBCs (Lu et al., 2009). The current study indicates at least some of these BCs are 
RBCs. Additionally, in the 5-HTR2a-GFP line, some weakly labeled cells were observed in the 
RGL. Therefore, the expression patterns of the transgene in these two lines, Cre and GFP, are 
likely to be similar, suggesting that the local chromatin environment does not significantly 
influence the transgene expression profile for the 5-HTR2a BAC promoter. 
For the Pcp2-cre line, based on the GFP fluorescence, our previous study showed that the 
GFP/Cre-expressing BCs were mainly RBCs (Ivanova et al., 2010). The results of this study, 
obtained by crossing with the reporter line, also showed that the majority of the tdTomato-
expressing BCs are RBCs, based on the co-labeling with an antibody against PKCα. In addition, 
the current study also revealed the expression of tdTomato in many type 6 CBCs as well as in 
some type 2 CBCs based on co-labeling with an antibody against Syt2. Furthermore, our results 
suggest that there are additional tdTomato labeled ON-type CBCs. Based on their terminal 
stratification level, these cells could be type 5 or 7 CBCs. The observation of these additional 
tdTomato-expressing BC types again suggests there is likely a weak expression of Cre 
recombinase in these cells. Although Pcp2 has been known to be rod-bipolar-cell specific, the 
expression of the transgene in other BC types in this mouse line is not totally surprising because 
the Pcp2-cre line was generated by pronuclear injection, in which the transgenic phenotype 
would be subject to the position effect.  
For Chx10-cre, the expression pattern of tdTomato resulting from crossing with the Cre 
reporter mouse was found to be markedly different from that of the GFP/Cre. First, there is 
strong expression of tdTomato fluorescence in Müller cells although this is not too surprising 
because there is weak expression of GFP/Cre in Müller cells (Ivanova et al., 2010) (also see Fig. 
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10). The expression of Cre in a subset of Müller glia cells in the Chx10-cre line was also 
previously reported (Zhang et al., 2004). Surprisingly, however, the tdTomato fluorescence was 
absent in the strongest GFP/Cre-expressing retinal BCs. On the other hand, the transgene 
expression profile delivered via rAAV vectors is more consistent with the Cre expression in this 
line (Rowan and Cepko, 2004; Ivanova et al., 2010). We observed robust Cre-mediated 
transgene expression in multiple types of BCs as well as in some Müller cells in this line through 
Cre-dependent DIO virus vectors. The reason for the lack of Cre/loxP recombination in the GFP-
Cre expressing BCs via the reporter line is not clear. It is possible that strong Cre expression 
causes rearrangement of genomic DNA or transgene silencing. In addition, the Chx10-cre line is 
well known to display mosaic expression in retinal progenitor cells (Rowan and Cepko, 2004). 
The mosaicism might contribute to the unexpected Cre recombination profile. It also remains to 
be determined whether this phenomenon is reporter mouse line dependent. Nevertheless, our 
results point to the importance of the validation of the expression profile through in vivo 
examination of reporter gene expression (Smith, 2011). 
Together, by directly crossing with the Cre reporter mouse line and validating by 
immunostaining, our studies reveal the existence of multiple Cre-expressing BC types in two of 
the transgenic lines. These two Cre mouse lines could be valuable tools for gene targeting and 
manipulation of BCs in the mouse retina. On the other hand, our results suggest that the Chx10-
cre mouse line may not be suitable for transgenic mouse line-based gene manipulation but can 
still be used for virus-based applications. 
In this study, we also evaluated Cre-dependent virus mediated gene delivery to retinal 
BCs by intravitreal injection. Our results show that an AAV2 vector construct with the 
combination of the Y444F capsid mutation and CMV promoter can effectively target the 
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transgene to retinal BCs. Thus, double floxed inverted AAV2 vectors could provide another 
valuable tool for gene targeting and manipulation in BCs of Cre transgenic mouse lines. There 
are several advantages for using virus-mediated targeting or delivery. First, using virus-mediated 
gene delivery would allow time-dependent control of gene manipulation. Second, virus-mediated 
gene delivery could be less subject to the complex problems arising from crossing with reporter 
lines. As shown in this study, for the Chx10-cre line, the Cre-mediated recombination in retinal 
BCs could not be achieved by crossing with the reporter mouse line but still could be achieved 
through Cre-dependent rAAV vector delivery. Furthermore, combining with promoters and virus 
serotypes could allow differential targeting to different retinal cell populations/types in Cre-
transgenic mouse lines.  
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CHAPTER 4 Heterogeneous expression of high-voltage-
activated calcium channels in retina bipolar cells 
SUMMARY 
In this study, we performed whole-cell patch-clamp recordings to investigate the 
electrophysiological, pharmacological and molecular biological properties of high-voltage-
activated (HVA) Ca2+ channels in retinal BCs in mice from retinal slice preparations. Ca2+ 
currents with different electrophysiological properties were observed among cone bipolar cells 
(CBCs), and between CBCs and rod bipolar cells (RBCs). First, large HVA Ca2+ currents were 
observed in OFF CBCs but not in ON-CBCs. Second, HVA Ca2+ currents among different BCs 
were found to show different activation potentials. Moreover, the HVA Ca2+ currents in RBCs 
display two components, a sustained and a transient component with the latter activated at more 
negative potentials. Our pharmacological results indicate the sustained and transient HVA Ca2+ 
currents originate from L- and P/Q type Ca2+ channels, respectively. Furthermore, using L-type 
Ca2+ channel knockout or deficient mouse lines, our results suggest that the L-type Ca2+ currents 
in RBCs are mediated mainly by α1C Ca2+ channels with a minor component from α1F Ca2+ 
channels. The findings of this study provide valuable insights into the role of voltage-gated Ca2+ 
channels in basic visual information processing in the retina as well as Ca2+ signaling and Ca2+ 
channel deficit-related diseases in the visual system. 
INTRODUCTION 
Retinal BCs, conveying visual information from photoreceptors to retinal third order 
neurons, are essential in segregating visual information into multiple parallel pathways in the 
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retina through their diversified cell types and physiological properties. BCs contained about ten 
types. Based on synaptic input, there is one single type of RBCs and multiple types of CBCs. 
BCs are also divided into ON and OFF types based on their light response polarity.  
Voltage-gated Ca2+ channels that can influence neuronal excitability and trigger 
neurotransmitter release could be responsible for the diversified physiological properties of 
different retinal BCs. Retinal BCs in mammalian retinas have been known to process both high-
voltage-activated (HVA) Ca2+ channels and low-voltage-activated (LVA) T-type Ca2+ channels. 
The HVA Ca2+ currents in retinal BCs, especially in mammalian RBCs, have been well studied 
and reported to be exclusively L-type. Immunostaining studies have reported a heterogeneous 
expression of four L-type Ca2+ channel α subunits, α1S (CaV1.1), α1C (CaV1.2), α1D (CaV1.3), 
and α1F (CaV1.4) in the retina, including in certain retinal BCs. Whether there are heterogeneous 
properties of HVA Ca2+ currents among different BCs still remains unclear. Also, the molecular 
composition of HVA Ca2+ current in retinal BCs, even in the most extensively studied RBCs, 
still remains elusive.  
To understand the functional roles of voltage-gated Ca2+ currents in BC processing, in 
this study we investigated the electrophysiological, pharmacological, and molecular properties of 
HVA Ca2+ currents in retinal BCs, especially RBCs by performing whole-cell patch-clamp 
recordings from retinal slice preparations in mice. To facilitate BC identification in in vitro 
recordings, BC-type specific GFP or Cre transgenic mice were used.  
METHODS 
Animals 
All animal handling procedures are approved by the Institutional Animal Care and Use 
Committee at Wayne State University and are in accordance with the NIH Guide for the Care 
58 
 
 
 
and Use of Laboratory Animals. All efforts were made to minimize the number of animals used 
and their suffering. 
 C57BL/6J, Pcp2-cre/GFP and the α1F mutant mice were purchased from Jackson 
Laboratory. 5-HTR2A-EGFP transgenic mice were obtained from Mutant Mouse Regional 
Resource centers (MMRRC; Line: DQ118). As described earlier, mainly RBCs and type 4 CBCs 
were labeled by GFP in the Pcp2-cre/GFP and 5-HTR2a-EGFP mouse lines, respectively. Gus-
GFP mice were provided by Dr. Robert F. Margolskee at Mount Sinai School of Medicine in 
New York. In this mouse line, the type 7 CBCs are labeled by GFP. 
The α1D knockout mice were kindly provided by Stressing’s lab in Austria. This mouse 
line was generated through homologous recombination together with a multi-stop codon cassette 
sequence (Platzer et al., 2000).  
The α1F mutant mouse line has been reported to be a naturally occurring null mutation 
for the α1F Ca2+ channel gene (Koschak et al., 2003). A recent study, however, reported the 
expression of a low level of α1F Ca2+ channel in this α1F mutant mouse strain due to alternative 
splicing (Doering et al., 2008). We will consider this fact in the interpretation of our 
experimental results. 
The α1C conditional knockout mice were kindly provided by the Geoffrey G. Murphy 
group at the University of Michigan (White et al., 2008). Since the global deletion of the α1C 
gene is lethal (Seisenberger et al., 2000), this α1C conditional knockout line was generated by 
introducing a mutation cassette flanked by two loxP sites into the α1C gene.  
To knockout the α1C gene, without affecting by animal development, the AAV2/2 
vectors carrying Cre-GFP sequence were injected intravitreally into the eyes of adult α1C 
conditional knockout mice. Figure 12A shows an AAV2/2 construct, 
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mGluR6enhancers+mSV40P–Cre–GFP-hGHpA, which is capable of expressing Cre in retinal 
BCs (our unpublished studies). For identifying those cells with Cre expression and Cre-mediated 
recombination, a second AAV2/2 vector expression of a double-floxed inverted open-reading 
frame (DIO) encoding channelrhodopsin-2-mCherry (ChR2-mCherry) with a ubiquitous CMV 
promoter was also intravitreally injected simultaneously. Figure 12B shows the Virus vectors 
construct carrying mCherry-ChR2, rAAV2 (Y444F)-CMV-DIO-ChR2-mCherry. Therefore, the 
α1C gene will be knocked out in the cells expressing mCherry (Fig. 12C). 
Virus Vector Injection 
The virus intravitreal injection procedure was as previously described (Ivanova et al., 
2010). Briefly, 1- to 2-month-old mice were anesthetized by intraperitoneal injection of a 
mixture of 120 mg/kg ketamine and 15 mg/kg xylazine. Under a dissection microscope, a small 
perforation was made in the temporal sclera region with a needle. A total of 1.5 μl of viral vector 
suspension in saline at a concentration of 1.3×1012 GC/ml and 5.6×1012 GC/ml for mGluR 
enhancer+mSV40P–Cre–GFP-hGHpA and rAAV2-(Y444F)-CMV-DIO-ChR2-mCherry, 
respectively, was injected into the intravitreal space through the perforation with a Hamilton 
syringe. The electrophysiogical recording was performed  about 1 month after the injection. 
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Figure 12. AAV2/2 Cre and reporter constructs A, AAV2/2 constructs carrying mGluR6 enhancers were 
inserted in the 5’ end of Cre-GFP fusion protein and driven by a basal mSV40P promoter. Cre-GFP 
sequence is followed by hGHpolyA. Both sides are flanked by long terminal repeat (LTR). B, AAV2/2 
serotype with a point mutation of capsid (Y444F) construct mediate expression of double-floxed inverted 
open reading frame (DIO) encoding channelrhodopsin-2-mCherry (ChR2-mCherry) with a ubiquitous 
promoter of CMV. C, The expression of mCherry mediated by the two virus vectors in a retinal vertical 
section. The positive BCs were marked with arrows. CMV: cytomegalovirus. WPRE: woodchuck post-
transcriptional regulatory element. hGHpA: a human growth hormone polyadenylation sequence. 
 
Table 6. List of animal lines for specific cell types recording. In wild type, α1D knockout, and α1F deficient 
animals the cell types were determined by axon terminal stratification in inner plexiform layer with dye filling. 
In Pcp2-cre-tdTomato line, type 2, 6 CBC and RBC can be identified with tdTomato expression. In 
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5HTR2a-cre-tdTomato line, type 4 CBC can be identified with tdTomato expression. In Gus-thy1-GFP line, 
type 7CBC can be identified with GFP expression. The type 2 CBC can also be labeled with CD15 antibody. 
Dissociation of bipolar cells 
BCs were dissociated from adult mice (C57/BL6J) 4 weeks of age by dissociation 
methods previously described (Pan and Lipton 1995). In brief, animals were deeply anesthetized 
with CO2 and killed by decapitation. Retinas were removed and placed in a Hanks’ solution (in 
mM): 138 NaCl, 1 NaHCO3, 0.3 Na2HPO4, 5 KCl, 0.3 KH2PO4, 1.25 CaCl2, 0.5 MgSO4, 0.5 
MgCl2, 5 HEPES-NaOH, and 22.2 glucose, with phenol red, 0.001% vol/vol; adjusted to pH 7.2 
with 0.3 N NaOH. The retinas were incubated for 50 min at 34–37°C in an enzyme solution that 
consisted of the normal Hanks’ described above, supplemented with 0.2 mg/ml DL-cysteine, 0.2 
mg/ml bovine serum albumin, and 1.6 U/ml papain, adjusted to pH 7.2 with 0.3 N NaOH. 
Following several rinses in Hanks’ solution, the retinas were dissociated by gentle trituration 
with a glass pipette mechanically. The resulting cell suspension was plated onto culture dishes 
for settle down. Cells were kept at room temperature and used for recordings within 5 hours after 
dissociation. 
Retinal slice preparation 
In brief, animals were deeply anesthetized with CO2 and killed by decapitation. The 
retina was dissected in carbongen-bubbled (95% O2 / 5% CO2) Ames’s solution (Sigma-Aldrich, 
St. Louis MO, USA). The cornea, iris and lens of the animal eye were dissected away. The 
eyecup was inverted on a piece of filter (Whatman, VWR; 10402506) with the photoreceptor 
layer up. Vertical slices (150 μM) were cut together with the filter by a scalpel blade on a 
chopper. The slices were kept in darkness to minimize photo damage in Ames’ solution at room 
temperature.  
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Whole-cell patch clamp recordings on dissociated cells 
Recordings with patch electrodes in the whole-cell configuration were made by standard 
procedures (Hamill et al. 1981) at room temperature (20–25°C) with an EPC-9 amplifier and 
PULSE software (Heka Electronik, Lambrecht/Pfalz, Germany). Electrodes were fabricated from 
borosilicate microcapillary tubes (VWR Scientific, West Chester, PA, US), coated with silicone 
elastomer (Sylgard; Dow Corning, Midland, MI), and fire-polished. The resistance of the 
electrode was 7–10 MΩ. Series resistance ranged from 10 to 40 MΩ and was not routinely 
compensated because the Ca2+ currents were small (≤100 pA). Cell capacitance was 
automatically canceled and recorded by EPC-9 amplifier and PULSE software. Test pulses were 
delivered once every 5–10 s for all recordings.  
To facilitate Ca2+ current recordings, voltage-activated K+ currents were suppressed by 
the inclusion of Cs+ and tetraethylammonium (TEA) in the recording electrode and extracellular 
solutions. Unless otherwise indicated, the recordings were performed in high- Ca2+ (10 mM) 
extracellular solution containing (in mM) 95 NaCl, 5 KCl, 10 CsCl, 20 TEA-Cl, 1 MgCl2, 10 
CaCl2, 10 HEPES, and 22.2 glucose, with phenol red, 0.001% vol/vol; pH 7.2. The electrode 
solution contained (in mM) 120 CsCl, 20 TEA-Cl, 1 MgCl2, 0.5 CaCl2, 5 EGTA, 10 HEPES, 0.5 
Na-GTP, and 2 Na-ATP, pH adjusted with CsOH to 7.4. Under these recording conditions, the 
voltage-activated K+ currents in BCs were mostly blocked because no significant outward 
current was observed when Ca2+ (10 mM) in the extracellular solution was replaced by 4 mM 
Co2+ and 6 mM Mg2+. The chloride reversal potential was around -20 mV using the above 
intracellular and extracellular recording solutions. Liquid junction potentials were measured to 
be 3 mV according to the procedure described by Neher (1992) and corrected. 
Whole-cell patch clamp recordings on retinal slices 
63 
 
 
 
During recordings, the slices were placed on a recording chamber. The chamber was 
continuously superfused with bubbled Ames solution at a rate of 2 ml/min. The electrode 
solution was the same as in the recording of dissociated cells. The fluorescent dye Alexa 488 or 
594 was added to the electrode solution at a concentration of 100 μM. The extracellular solution 
contained (in mM) 95 NaCl, 5 KCl, 10 CaCl2, 10 CsCl, 20 TEA-Cl, 1 MgCl2, 10 HEPES, and 
22.2 glucose, with phenol red, 0.001% v/v, pH 7.2. In all recordings, 100 μM bicuculline, 100 
μM TPMPA, 2 μM strychnine, and 1 μM tetrodotoxin (TTX) were included in the extracellular 
solutions.  
The same electrode solution was used as described above. Liquid junction potential (3 
mV) was corrected. Pipette resistances ranged from 7 to 10 MΩ. Whole cell input resistances of 
BCs were at least 1GΩ. Cells were voltage-clamped in whole cell mode. For recording HVA 
Ca2+ currents, the membrane potential of the cells was holding at -50 mV. The voltage-gated 
Ca2+ currents were activated by ramp stimulus from -50 mV to 20 mV at a speed of 100 mV/1S 
and by depolarizing steps ranging from -45 mV to -15 mV, with a 5 mV increment. 
Identification of bipolar cell types in dissociated cell and slice preparations 
In dissociated preparation, type 4 CBCs were identified based on GFP from the 5HTR2a-
GFP transgenic mouse line. RBCs were identified based on GFP from the Pcp2-cre/GFP 
transgenic mouse line or their characteristic morphology.  
In retinal slice preparation, we used the following three ways to identify the cell types: (1) 
stratifications of axon terminals in the IPL using recording pipettes filled with dye Alexa 488 or 
Alexa 594 dye (100 μM); (2) the expression of GFP using BC specific transgenic mouse lines; (3) 
for type 2 CBCs, live antibody staining with CD15 as described below.  
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The type 2 CBCs were identified by staining with a CD15 antibody as previously 
described (Jakobs et al., 2003). Briefly, the mouse monoclonal IgM antibody against the CD15 
epitope (1:50, BD PharMingen, San Diego, CA, US) was dissolved in the extracellular solution. 
The retinal slices were immersed in the primary antibody solution for 2 hours, and then washed 
for 30 mins with perfusion of the extracellular solutions. Secondary antibody donkey anti mouse 
IgG Alexa 488 (1:200, green fluorescence, Molecular Probes, Invitrogen, Carlsbad, CA) was 
applied for 1 hour, and then washed away for 30 mins. The stained retinal slices were then ready 
for patch clamp recordings. The summary of BC type’s identification methods is showed in table 
6. 
Chemicals 
Nimodipine, nifedipine, BayK 8644, and tetrodotoxin (TTX) were purchased from 
Research Biochemicals (Natick, MA). The ω-Agatoxin IVA (RTA-500，ω-Conotoxin (C-300) 
and SNX482 (RTS-500) were purchased from Alomone (Alomone Labs, Har Hotzvim, 
Jerusalem, Israel). Mibefradil was a kind gift from F.Hoffmann (La Roche, Basel, Switzerland). 
Other chemicals were purchased from Sigma (St. Louis, MO). Chemical agents were applied by 
local perfusion. In the local perfusion, chemicals were applied to the cells by five-barreled 
gravity-driven superfusion pipettes (modified from Carbone and Lux 1987) placed about 200–
300 μm away from the cell being recorded. 
Statistical analysis 
Data were analyzed off-line using PULSE-FIT (Heka Electronik) and ORIGIN programs 
(Microcal Software, Northampton, MA). One way ANOVA was used to compare data. In all 
results, the significance was accepted as p < 0.05. Date are presented as mean ± SEM. 
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RESULTS  
Part 1. Comparison of HVA Ca2+ currents in acutely dissociated cell preparations 
To assess the properties of voltage-gated Ca2+ currents in CBCs and RBCs, we first 
performed whole-cell patch-clamp recordings on acutely dissociated RBCs and type 4 CBC cells 
from the two BC specific-GFP transgenic mouse lines, pcp2-GFP for RBCs and 5HTR2a-GFP 
for type 4 CBCs as described above. The BCs were identified by their GFP fluorescence. In these 
recordings, voltage-gated Ca2+ channels were isolated by the blockade of other voltage-gated 
membrane channels (see Methods). The cell’s membrane potential was held at -80 mV and 
depolarized by a voltage ramp from -80 to +40 mV at a speed of 100 mV/ s and by a series of 
400 ms test pulses ranging from -60 mV to +30 mV. To isolate the Ca2+ currents, extracellular 
solutions contain 10 mM Cs+ and intracellular solutions contain 120 mM Cs+ to block K+ 
channels.  
Figure 13A and B show the typical voltage-gated Ca2+ currents elicited from type 4 CBCs 
with ramp stimulus and step pulses, respectively. Interestingly, we did not observe any 
significant voltage-gated Ca2+ currents (n = 10). The results contrasted with those in retinal slice 
recordings in which both HVA and LVA Ca2+ currents were observed (see below).  
Figure 13C and D show the voltage-gated Ca2+ currents recorded from RBCs. In RBCs, 
voltage-gated Ca2+ currents were evoked at around -60 mV and reached their peak around -40 
mV to -30 mV. It should be noted that the observed currents in RBCs in dissociated cells are 
mainly T-type (Pan, 2000). Although RBCs also express L-type Ca2+ channels, the current is 
located at the axon terminals and only becomes apparent by the application of L-type Ca2+ 
channel agonist BayK8644. 
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Figure 13. Voltage-activated Ca2+ currents of type 4 CBCs and RBCs recorded from acutely dissociated 
cell preparations. A-B, Type 4 CBCs show no apparent voltage gated Ca2+ currents. A: Currents were 
evoked by a voltage ramp ranging from -80 to 40 mV. B: Currents were evoked by three 400 ms test pulses 
from the holding potential of -80 mV to -60, -50, and -30 mV.  C-D, Typical Ca2+ currents recorded from on 
RBCs. C, Ca2+ currents were evoked by a voltage ramp ranging from -80 to 40 mV. D, Ca2+ currents were 
evoked by three 400 ms test pulses from the holding potential of -80 mV to -60, -50, and -40 mV, 
respectively.   
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Part 2. Comparison of HVA Ca2+ currents among CBCs and RBCs in retinal slices 
To investigate the properties of voltage-gated Ca2+ currents in retinal BCs under more 
physiological conditions, in all the following experiments, we performed whole-cell patch-clamp 
recordings to characterize the HVA Ca2+ currents in the CBCs and RBCs in retinal slice 
preparations.  
To isolate the HVA Ca2+ currents from LVA in voltage ramp stimulation, the HVA Ca2+ 
currents were recorded from the holding potential of -50 mV to inactivate LVA T-type Ca2+ 
currents. The HVA Ca2+ currents among different BCs were evaluated by both ramp and step 
pulse stimulation protocols.  
The heterogeneous properties of HVA Ca2+ currents were observed among the BCs. First, 
large HVA Ca2+ currents were observed in all recorded OFF-CBCs, type 2, type 3, type 4 (see 
Fig. 14A- F). In contrast, HVA Ca2+ currents in recorded ON-CBCs, type 6 and type 7, were 
found to be small (see Fig. 14G, H and J, K).  
Second, although prominent HVA Ca2+ currents were also observed in RBCs (Fig. 14I, L, 
and M), the kinetics of the HVA Ca2+ currents of RBCs, were markedly different from those of 
CBCs. As shown in Fig, 14D, E, and F, the HVA calcium currents of OFF CBCs, type 2, 3, and 
type 4 CBCs do not show significant time-dependent inactivation. In contrast, the HVA Ca2+ 
currents of RBCs exhibit fast inactivation, especially at the relatively negative test potential (Fig. 
14L). 
Third, the voltage-dependent activation of HVA among CBCs was found to be different. 
This was particularly noticeable when the I-V relationships of type 2 and type 4 CBCs were 
compared both by ramp stimulus and test pulses (Fig. 15 A-D). Both the threshold and peak Ca2+ 
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current activation potentials of type 2 CBCs were significantly shifted to more positive potentials 
than that of type 4 CBCs (Fig. 15E).  
Finally, it is also interesting to note that  the large HVA Ca2+ currents in type 4 CBCs 
observed in slice preparations (see Fig. 15C) contrast to the results recorded from  dissociated 
cells (Fig. 12A). The failure to detect voltage-gated Ca2+ currents in type 4 CBCs in acutely 
dissociated cell preparations appeared to be unique to this cell type, because T-type voltage-
gated Ca2+ currents were observed in other BC types, such as RBCs (see below). A possible 
explanation is that all voltage-gated Ca2+ channels in type 4 CBCs are located at the axon 
terminals which could be lost during cell dissociation. Alternatively, the loss of voltage-gated 
Ca2+ currents could be due to a down-regulation mechanism, possibly related to the enzymatic 
treatment.
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Figure 14. L-type voltage-gated Ca2+ currents recorded from different BCs. A-C, G-I, Ca2+ currents were 
evoked by a voltage ramp from -50 to 20 mV from the holding potential of -50 mV. D-F, J-L, Ca2+ currents 
were evoked by a series of 500 ms test pulses from the holding potential of -50 mV with an incremental 
step of 5 mV. D, Individual traces were shown evoked by test potential to -20 mV and -10mV at holding 
potential to -50 mV.  E, F, J-L, Individual traces were shown evoked by test potential to -35 mV and -25 mV 
from the holding potential of -50 mV.  A, D, type 2 CBCs. B, E, type 3 CBCs.  C, F, type 4 CBCs. G, J, type 
6 CBCs. H, K, type 7 CBCs. I, L, RBCs. M, Statistical data of the peak current amplitudes of HVA Ca2+ 
currents for BCs. The data were measured from the ramp stimulus. 
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Figure 15. Comparison of voltage-dependent activation of HVA Ca2+ currents between type 2 and 4 CBCs. 
A, B, The representative recordings of HVA Ca2+ currents from type 2 in A and type 4 in B CBCs elicited by 
test pulses. C, The I-V plots for the Ca current for the recordings shown in A and B. D, Comparison of HVA 
Ca2+ currents between type 2 in A and type 4 in B CBCs elicited by ramp stimulus from -50 to 20 mV from 
the holding potential of -50 mV. E, Statistical data of the threshold and peak activation potentials of HVA 
Ca2+ currents for type 2 and type 4 CBCs. The data were measured from the ramp stimulus.  
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Part 3. Electrophysiology, pharmacology and molecular properties of HVA Ca2+ 
currents in RBCs 
3-1. The HVA Ca2+ current of RBCs exhibits both sustained and transient 
components  
Since the L-type Ca2+ current is usually known to display no or slow time-dependent 
inactivation, our finding of the fast inactivation of the HVA Ca2+ currents in RBCs contrasted 
with the common belief that HVA Ca2+ currents in all BCs including RBCs are L-type. This 
unexpected finding therefore prompted us to investigate in detail the properties of HVA Ca2+ 
currents in RBCs. 
Again, to characterize the HVA Ca2+ currents in RBCs, HVA Ca2+ currents were evoked 
by a voltage ramp from -50 to +20 mV or by a series of 400 ms depolarizing test pulses ranging 
from -40 mV to +20 mV from the holding potential of -50 mV. Fig. 16 shows sample recordings 
of HVA Ca2+ currents of RBCs from the C57/BL6J mouse line. In ramp stimulation, a prominent 
HVA Ca2+ current was activated at the potential >-40 mV (Fig. 16A). The HVA Ca2+ currents 
elicited by test pulse stimuli show fast inactivation (Fig. 16B). The current-voltage (I-V) 
relationships of the inward HVA Ca2+ currents measured at the peak and the plateau (at the end 
of stimulation pulse) are shown in Figure 16C. As evidenced from Figure 16B and C, a transient 
current appeared at the relatively hyperpolarized test membrane potentials < -30 mV and reached 
a peak around -20 mV. At more depolarized test potentials, a sustained component of current 
appeared. The sustained current reached a peak around -15 to -10 mV. The inactivation time 
constant obtained by fitting the current decay time course was found to be test-potential 
dependent but the time constant becomes slower at more depolarized test potentials (Fig. 16D 
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and E). These results suggest that the HVA Ca2+ currents of RBCs contain two components: a 
sustained component and a transient component.  
The average peak Ca2+ current of RBCs is 48.6 pA ± 2.4 pA (n = 12) in step stimulations. 
The average Ca2+ currents of the sustained component at the end of the 500 ms step stimulation 
of RBCs is 31 pA ± 1.8 pA (n = 12) and the average whole cell capacitance of RBCs is 4.59 pF ± 
0.6 pF (n = 24).   
To investigate further the properties of these two components of the current, in the 
following experiments, the transient component of the Ca2+ current was evoked by the test pulse 
to -35 mV from the holding potential of -50 mV. The sustained component together with the 
transient one was evoked by the test pulse to -25 mV.  
First, both the transient and sustained components of the current were not observed from 
RBCs without axon terminals (n = 9) (lost during the slice section). In contrast, the T-type Ca2+ 
currents were still present (see Fig. 17). This result suggests that both components of the HVA 
Ca2+ current in RBCs are located exclusively at the axon terminals, which is consistent with all 
previous reports.   
73 
 
 
 
 
Figure 16. Voltage-gated Ca2+ currents recorded from the GFP labeled RBCs in the C57/BL6J mouse line. 
A, Ca2+ currents were evoked by a voltage ramp from -50 to 20 mV from the holding potential of -50 mV. B, 
Ca2+ currents were evoked by a series of 400 ms test pulses from the holding potential of -50 mV. C, The 
current-voltage (I-V) relationships of the inward HVA Ca2+ currents measured at the peak (red triangles) 
and the plateau (black circles; at the end of stimulation pulse) for the cell shown in B. D, Ca2+ currents were 
evoked by four test pulses of 400 ms test pulses of -40 mV to -10 mV from the holding potential of -50 mV. 
E, The relationship of inactivation time constant and test/potential. The inactivation time constants were 
obtained by fitting the decay phase of the currents with an exponential function. 
74 
 
 
 
 
Figure 17. Voltage-activated Ca2+ currents from a soma of RBC without axon terminal. A, Currents were 
evoked by a voltage ramp from -80 to 20 mV from the holding potential of -80 mV (black line) and -50mV 
(red line). B, Individual traces evoked by 200 ms test pulses of -40 mV to 20 mV from the holding potential 
of -80 mV. In A-B, there were only T-type current on axonless RBCs. This means HVA Ca2+ channels 
expression exclusively at axon terminal of RBCs. In C, the single trace was shown evoked by of 200 ms 
test pulses of -40 mV from the holding potential of -50 mV.  
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We next examined the possibility of whether the transient component of the current could 
be contaminated by other currents including Ca2+ dependent currents or due to Ca2+ dependent 
inactivation. First, the transient current is TTX insensitive (data not shown). This excludes the 
possible involvement of voltage-dependent Na+ currents in RBCs. Second, we found that both 
components of the current are Ca2+ dependent because no inward current was observed in Ca2+-
free extracellular solutions (n = 10) (data not shown). In addition, both components of the current 
were blocked by 100 μM cadmium (n = 7) (Fig. 18). Furthermore, a similar pattern of Ca2+ 
currents were observed with an extracellular solution where Ca2+ was replaced by Ba2+ (n = 20) 
(Fig. 19), suggesting that the transient property of the Ca2+ current is unlikely due to Ca2+-
dependent inactivation or Ca2+ activated other currents. Furthermore, the transient current could 
not be mediated through the transient receptor potential-like channels (TRPM1) located in the 
dendrites of RBCs. This is because the current is absent in RBCs without terminals (see Fig. 17). 
Taken together, these results indicate that the observed HVA current in RBCs was the Ca2+ 
current.   
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Figure 18. Effects of Cadmium on Ca2+ currents in RBCs. Ca2+ currents were evoked by the test potential 
of -35 mV in A and -25 mV in B. A, at the membrane potential of -35 mV, there was only transient 
component. The transient component can be totally blocked by 100 μM Cadmium. B, at the membrane 
potential of -25 mV, there were both transient and sustained component. Both of the transient and 
sustained components can be totally blocked by 100 μM cadmium. 
3-2. The sustained component of Ca2+ current in RBCs was coming from L-type 
channels 
Next, we examined the pharmacological properties of the two components of HVA Ca2+ 
currents in RBCs. It is known that L-type Ca2+ currents are DHP-sensitive (Carbone and Lux, 
1984). For example, the current can be enhanced by DHP agonists, such as BayK8644, and 
blocked by DHP antagonists, such as nimodipine. We found that the sustained but not the 
transient component of Ca2+ currents was enhanced by 1 μM BayK-8644 (n = 14) (Fig. 20 A and 
B). Furthermore, the sustained but not the transient component of Ca2+ currents can be blocked 
by 100 μM nimodipine (n = 13) (Fig. 20 C and D). These results indicated that the sustained but 
not the transient component of the HVA Ca2+ currents was from L-type channels. These results 
are in part consistent with the early reports that RBCs process sustained L-type Ca2+ currents, but 
our results indicate RBCs also process a non-L-type Ca2+ current.  
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Figure 19. Comparison of Ba2+ and Ca2+ ion selectivity for the high voltage activated Ca2+ currents of RBCs. 
A-D, Currents were evoked by depolarizing to -35 mV from the holding potential of -50 mV. A, C, Currents 
were evoked by depolarizing to -35 mV from the holding potential of -50 mV. B, D, Currents were evoked 
by depolarizing to -25 mV from the holding potential of -50 mV. A-B, showed the original current amplitude. 
C-D, show normalized current based on recording in 10mM Ca2+ solution. In A, B, the currents were larger 
in 10mM Ba2+ comparing to 10 mM Ca2+. But the inactivation properties of the current in 10mM Ba2+ were 
mostly the same as in 10 mM Ca2+.  Solutions containing 10 mM Ba2+ or 10 mM Ca2+ were applied by local 
perfusion. 
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Figure 20. Comparison of the effect in nimodipine and BayK 8644 on the transient and sustained 
components of HVA Ca2+ currents on RBCs. A and C, Sample traces of Ca2+ currents evoked by 500 ms 
test potentials at -35 mV from the holding potential of -50 mV. B and D, Sample traces of Ca2+ currents 
evoked by 500 ms test potentials at -25 mV from the holding potential of -50 mV. A and B were recorded in 
10mM Ca2+ solution in the presence of 1 μM BayK 8644. C and D were recorded in 10mM Ca2+ solution in 
the presence of 10 μM nimodipine.  
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3-3. The transient component of Ca2+ current in BCs was coming from P/Q-type 
channels 
We further investigated the pharmacological properties of the transient component of the 
Ca2+ current. First, the transient component of the HVA current could not be blocked by the T-
type channel blocker, mibefradil (2μM) (n =16) (Fig. 21A) although mibefradil at this 
concentration could mostly block the T-type Ca2+ current evoked from the RBCs from a more 
negative holding potential (Fig. 21B). Therefore, the transient component is not a T-type Ca2+ 
current. 
Next, we examined non-DHP sensitive HVA Ca2+ channel blockers. We found that the 
transient component was not affected by the N-type Ca2+ channels blocker ω-conotoxin GVIA (n 
= 8) and the R-type Ca2+ channel blocker SNX482 (n = 7) (Fig. 22 A and B). On the other hand, 
the transient component but not the sustained component was largely blocked by a P/Q type Ca2+ 
channel blocker ω-agatoxin IVA (n = 13) (Fig. 22C and D). On average, 53.6% ± 1.8% of the 
currents was blocked by 200 nM ω-agatoxin IVA. Thus, our results indicate the transient 
component of the HVA originate from P/Q type Ca2+ channels. It should be noted that the 
voltage activation and the speed of inactivation properties of P/Q type Ca2+ channels are between 
L-type and T-type channels, (Nowycky et al., 1985; Fox et al., 1987). The transient component 
of HVA Ca2+ appears to show this feature.  
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Figure 21. Effects of T-type channel blocker mibefradil on HVA Ca2+ currents in RBCs. A, Ca2+ currents 
were evoked by the test potential of -35 mV at membrane potential holding at -50 mV. At the membrane 
potential of -35 mV, there was only transient component. The transient component cannot be blocked by 2 
μM mibefradil. B, Ca2+ currents were evoked by the test potential of -40 mV at membrane potential holding 
at -80 mV. At the membrane potential of -40 mV, there were only low voltage activated T-type Ca2+ currents. 
The T-type currents can be blocked by 2 μM mibefradil.  
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Figure 22. Effects of non-DHP channel blockers on HVA Ca2+ currents in RBCs. Sample traces of Ca2+ 
currents evoked by 500 ms test potentials at -35 mV from the holding potential of -50 mV. A, Currents were 
evoked in 10 mM Ca2+ (black) and 10 mM Ca2+ plus 20 nM N type blocker ω-conotoxin GVIA (grey). The ω-
conotoxin cannot block the transient component. B, Currents were evoked in 10 mM Ca2+ (black) and 10 
mM Ca2+ plus 400 nM R type blocker SNX482 (grey). SNX-482 cannot block the transient component 
either. C, Currents were evoked in 10 mM Ca2+ (black) and 10 mM Ca2+ plus 200 nM P/Q type blocker ω-
agatoxin IVA (grey). The ω-agatoxin IVA can block the transient component. D, Currents were evoked by a 
voltage ramp from -50 to 10 mV from the holding potential of -50 mV in 10 mM Ca2+ (black), and 10 mM 
Ca2+ plus 200 nM P/Q type blocker ω-agatoxin IVA (grey).   
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Part 4. The molecular composition of L-type Ca2+ current in RBC  
We then investigated the molecular composition of L-type Ca2+ currents in RBCs by 
using Ca2+ channel knockout or deficient mouse lines. In this set of experiments, the magnitude 
of L-type Ca2+ currents in RBCs was evaluated by the ramp stimulation from the holding 
potential of -50 mV. This is based on the observation that although RBCs process P/Q type Ca2+ 
current, the P/Q type Ca2+ current did not contribute significantly to the peak inward Ca2+ current 
evoked by the ramp stimulus. This is because the application of ω-agatoxin did not show 
significantly affecting the peak inward current evoked by ramp stimulation (shown in Fig. 22D). 
This would not be unexpected because the P/Q Ca2+ current shows relatively fast inactivation 
and the current is not prominent during slow ramp stimulation.  
We first recorded the L-type Ca2+ current from a α1D knockout transgenic line and a α1F 
deficient mouse line. The global knockout α1D mice were generated through homologous 
recombination together with a multi stop codons cassette sequence (Platzer et al., 2000). The α1F 
mutant mouse line has been reported to be a naturally occurring null mutation for the α1F Ca2+ 
channel gene (Doering et al., 2008). In ramp stimulation, the magnitude of L-type Ca2+ currents 
recorded from the α1D-/- knockout mice was not found to be different from that of wt mice (Fig. 
23). On the other hand, the magnitude of L-type Ca2+ currents recorded from the α1F deficient 
mice knockout mice was found to be moderately reduced (Fig. 24). The average peak current 
from α1D-/- knockout mice is 28.7 ± 2.8 pA (n = 27) which is significantly smaller than that of 
the wt mice (39.2 ± 1.9 pA; n = 36) (see Fig. 26). On the other hand, both sustained and transient 
HVA currents were observed in both Ca2+ knockout and deficient lines (Fig. 23B and 24B). 
These results suggest at least a partial involvement of the α1F Ca2+ channel subunit but 
not the α1D Ca2+ channels in RBCs. However, since in both mouse lines, the gene is deleted 
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during development, the results could be complicated by possible gene replacement during the 
development. In addition, a more recent study reported that the α1F Ca2+ deficient mouse line 
used still presents a minor splicing variant of the α1F gene.   
We further investigated the molecular composition of the L-type Ca2+ current in RBCs by 
using a α1C conditional knockout mouse line. The α1C conditional knockout line was generated 
by introducing a mutation cassette flanked by two loxP sites into α1C gene (White et al., 2008). 
To circumvent the possible gene replacement that could occur during development, the knockout 
of the α1C gene was achieved by injected an AAV2/2 vector carrying Cre-GFP sequence into the 
eye of α1C-/- or α1C+/- conditional knockout mice (see Methods). To facilitate the identification 
of Cre-positive cells with Cre-mediated recombination, a second virus vector carrying mCherry 
was co-injected. Both viruses can infect RBCs in the retina (see Methods; Fig. 12). The 
recordings were made from the mCherry positive RBCs.  
The L-type Ca2+ current from the mCherry-positive RBCs in α1C-/- or α1C+/- conditional 
knockout mice was compared with that of RBCs from wt mice (C57B/6J), as well as from the 
mCherry negative RBCs in the virus injected α1C conditional knockout mice. Again, the L-type 
Ca2+ current was assessed by the ramp stimulation from the holding potential of -50 mV.  
As assessed by ramp stimulus, the L-type Ca2+ currents from the mCherry-positive RBCs 
of both α1C-/- or α1C+/- knockout mice, especially α1C-/- knockout mice, were markedly smaller 
than those of the control (Fig. 25 A-C). The average peak inward currents evoked of RBCs by 
ramp stimulus are 8.53 ± 0.7 pA (n = 9) for α1C-/- and 23.3 ± 2.4 pA (n = 8) for α1C+/- (see Fig. 
26).  
We also compared the L-type Ca2+ current evoked by test pulses among mCherry-
expressing RBCs from α1C-/- conditional knockout mice, RBCs in wt mice, the RBCs from 
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mCherry-negative α1C-/- conditional knockout mice. As shown in Figures 25D-F and 27, the 
sustained component of HVA Ca2+ current in the mCherry-positive RBCs were markedly 
reduced compared to the controls. The average peak current and the peak plateau current 
measured at the end of the 400 ms of the test potential were 26.3 ± 2.3 pA and 4.95 ± 0.89 pA (n 
= 6), respectively. The values are significantly smaller than those from both controls. From wt 
mice, the average peak total current and the peak plateau current are 50.6 ± 2.5 pA and 31 ± 2 pA 
(n = 12), respectively. From mCherry-negative α1C-/- conditional knockout mice, the average 
peak total current and the peak plateau current are 46.7 ± 3.3 pA and 30.2 ± 3.8 pA (n = 8), 
respectively.  
Taken together, our results suggest that the majority of the L-type Ca2+ current in RBCs is 
from the α1C Ca2+ channels.   
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Figure 23. Voltage activated Ca2+ currents recorded from RBCs in the α1D-/- mouse line. A, Currents were 
evoked by a voltage ramp from -50 to 20 mV from the holding potential of -50 mV. B, Currents were evoked 
by a series of 500 ms test pulses from the holding potential of -50 mV.  
 
Figure 24. Voltage activated Ca2+ currents recorded from RBCs in the α1F-/- mouse line. A, Currents were 
evoked by a voltage ramp from -50 to 20 mV from the holding potential of -50 mV. B, Currents were evoked 
by a series of 500 ms test pulses from the holding potential of -50 mV.  
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Figure 25.  Voltage activated Ca2+ currents recorded from the Cre positive RBCs in the α1C-/- mouse line. 
A, Currents were evoked by a voltage ramp from -50 to +20 mV from the holding potential of -50 mV in 
α1C-/- RBCs. B, Currents were evoked by a voltage ramp from -50 to +20 mV from the holding potential of -
50 mV in mCherry negative RBCs in α1C conditional knockout animals. Because these cells had no cre 
recombinase enzyme expression, these cells were recorded as control with normal α1C channels 
expression pattern as wild type control cells. C, Currents were evoked by a voltage ramp from -50 to +20 
mV from the holding potential of -50 mV in WT RBCs. D, Currents were evoked by a series of 500 ms test 
pulses from the holding potential of -50 mV in Cre positive RBCs in α1C conditional knockout animals. In 
these cells the α1C channels were knockout. E, Currents were evoked by four test pulses of 500 ms test 
pulses from the holding potential of -50 mV in in Cre negative RBCs. F, Currents were evoked by four test 
pulses of 500 ms test pulses from the holding potential of -50 mV in wild type cells. 
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Figure 26. Average current amplitude of HVA Ca2+ currents recorded from the BCs with ramp stimulation in 
the Ca2+ channel knockout line and wild type animals. Comparison of current amplitude of HVA Ca2+ 
currents in WT, α1C+/-, α1C-/-, α1D-/-, α1F-/- RBCs from ramp current. Ca2+ currents were evoked by a 
voltage ramp from -50 to 20 mV from the holding potential of -50 mV.  
 
Figure 27. Mean current amplitude of HVA Ca2+ currents recorded from the RBCs in the α1C Ca2+ channel 
knockout and wild type animals. Mean peak current for WT mice, normal cells without cre recombinase in 
α1C conditional knockout mice, and α1C conditional knockout (-/-) mice obtained from the indicated 
number of cells. Currents were evoked by a series of 500 ms test pulses from the holding potential of -50 
mV.  
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DISCUSSION 
In this study, we made a number of new findings about the electrophysiological and 
molecular properties of HVA Ca2+ currents in retinal BCs. First, we revealed the heterogeneous 
properties of HVA Ca2+ currents among CBCs and between CBCs and RBCs. We found that 
OFF-CBCs as well as RBCs possess prominent HVA Ca2+ currents. In contrast, HVA Ca2+ 
currents in ON-CBCs were small or barely detectable in some cases. We also found that the 
voltage-dependent activation of HVA Ca2+ currents among OFF CBCs was different. In addition, 
the HVA Ca2+ currents in CBCs were found to be largely sustained. In contrast, the HVA Ca2+ 
current in RBCs exhibited two components, both sustained and transient. Furthermore, we found 
for the first time the RBCs in mouse retinas possess P/Q type of HVA Ca2+ channels in addition 
to L-type HVA Ca2+ channels. Finally, our results suggest that the L-type HVA Ca2+ currents in 
RBCs are mainly mediated by α1C Ca2+ channels.   
Heterogeneous properties of HVA Ca2+ currents among BCs and functional 
implications 
In this study, we found that all of the recorded OFF-CBCs, type 2, 3, and 4, show large 
HVA Ca2+ currents, which are particularly large in certain types of OFF CBCs, such as type 3 
CBCs. In contrast, the HVA Ca2+ currents recorded from ON-CBCs, types 6 and 7, were found 
to be small or barely detectable in some cases. Relatively large HVA Ca2+ current was also 
observed in RBCs, which is an ON-type cell. Could the difference in the amplitude of HVA Ca2+ 
currents observed in electrophysiological recordings reflect their different cellular localization? 
For example, could it be possible that the Ca2+ channels localized at the distal terminal of BCs 
may not be detected with the patch-clamp recording on the cell soma? We consider this unlikely.  
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First, because the axons of BCs are relatively short, BCs in general have been considered 
to be largely isopotential. In addition, as also confirmed in this study, large HVA Ca2+ currents 
were recorded from RBCs although the HVA Ca2+ channels in RBCs are known to be present 
almost exclusively at the axon terminals. Similarly, large HVA Ca2+ currents were also observed 
in type 4 CBCs while our results suggest that HVA Ca2+ channels in type 4 CBCs are likely also 
localized at the axon terminals because no HVA Ca2+ current was observed in isolated 
preparations. In addition, type4 CBCs without terminals have no HVA Ca2+ currents in retinal 
slice preparations. Therefore, the different amplitudes of HVA Ca2+ currents observed among 
different BCs likely reflects the expression level of the HVA Ca2+ channels among these cells. 
Retinal BCs of all types have been known to process both HVA Ca2+ currents and LVA 
T-type Ca2+ currents. Also, both Ca2+ currents have been reported to be capable of triggering 
transmitter release at the axon terminals. The different current amplitude of HVA Ca2+ currents 
observed between ON and OFF-CBCs may suggest that the neurotransmitter release from these 
two classes of BCs might be mediated by HVA Ca2+ channels and LVA T-type Ca2+ channels, 
respectively. Since HVA Ca2+ channels and LVA T-type Ca2+ channels differ in their voltage-
dependent activation and time-dependent inactivation (Pan, 2000; Catterall et al., 2005), the 
potential differential involvement of these two types of Ca2+ currents in different BC classes 
could have significant functional consequence for regulating BCs’ excitability and 
neurotransmitter release.  
Furthermore, our results show the voltage-dependent activation of HVA Ca2+ currents 
among CBCs are different. Specifically, we found that the I-V curve of the HVA Ca2+ currents in 
type 2 CBCs was shifted to more positive potentials than that of type 4 CBCs. The average 
threshold potential and peak potential in type 2 CBCs are about 10 mV and 15 mV more positive 
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than that of type 4 CBCs, respectively. As commonly believed, the HVA Ca2+ currents in CBCs 
are likely to be L-type (Protti and Llano, 1998; Protti et al., 2000). L-type Ca2+ channels can be 
formed by four different α1 Ca2+ channel subunits, α1S (CaV1.1), α1C (CaV1.2), α1D (CaV1.3), 
and α1F (CaV1.4), along with other associated Ca2+ channel subunits, which are known to exhibit 
distinct properties, including voltage-dependent activation, reviewed in (Catterall, 1995, 2000). 
Our results thus imply the expression of different molecular compositions of L-type Ca2+ 
currents among CBCs. Again, the expression of different properties of HVA Ca2+ channels 
among different BCs, such as among CBCs, could have significant functional consequence for 
regulating BC excitability and neurotransmitter release. 
Expression of P/Q type HVA Ca2+ channels in RBCs 
An unexpected finding of this study is the expression of both the L-type and P/Q type 
calcium channels in RBCs. Up to the present time, all the HVA Ca2+ channels in retinal BCs, 
including RBCs, were reported to be L-type (Protti and Llano, 1998; Pan, 2000; Protti et al., 
2000; Pan, 2001). Previously, all of the HVA Ca2+ currents in BCs were reported to exhibit slow 
or no time-dependent inactivation (von Gersdorff and Matthews, 1996; Shen et al., 2006). 
However, in this study in mice, we were surprised to observe a transient component of HVA 
Ca2+ current in RBCs in addition to a sustained one. Consistent with many previous reports our 
results indeed show that RBCs express L-type Ca2+ channels because a sustained Ca2+ current 
that was sensitive to DHP antagonist and agonist was observed. On the other hand, the transient 
component of the Ca2+ currents was activated at more negative membrane potential than the 
sustained one.  
In this study, we demonstrate that the transient component of HVA Ca2+ current is 
mediated by P/Q Ca2+ channels. First, our results show that the transient current is not due to a 
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contamination of other currents or due to Ca2+-dependent inactivation. Second, our 
pharmacological results show that the current is not blocked by L-, T-, N-, and R-type Ca2+ 
channel blocker but by P/Q-type Ca2+ channel selective blocker, ω-agatoxin. In addition, the 
expression of non-L-type Ca2+ channels in RBCs is also consistent with the results of Ca2+ 
channel knockout studies because the transient component of HVA Ca2+ current is persistent in 
all of L-type Ca2+ channel knockout or deficient mouse lines.  
The P/Q type (Cav2.1) subfamily is a major component of Ca2+ channels in trigger 
transmitter release in neuromuscular junctions and CNS (Olivera et al., 1994). The non-DHP 
sensitive Ca2+ channels are highly rich in presynaptic terminals in CNS neurons (Catterall, 1998). 
The fast inactivation and blockage by ω-Agatoxin IVA are hallmarks of P/Q type Ca2+ currents 
(Mintz et al., 1992; Sather et al., 1993). P/Q type Ca2+ channels also possess intermediate 
voltage-dependent and Ca2+ -dependent properties between L- and T- type Ca2+ channels 
(Catterall et al., 2005). 
It is worth mentioning that the P type α1 subunit and the Q- type subunit are two 
alternative splicing products of the same gene (Stea et al., 1994). The P-type seems to be the 
α1Ab splice variant and the Q-type is α1Aa. There are several different properties between these 
two subtypes. First, the blocking efficiency of ω-Agatoxin IVA is high to P-type (Kd = 1-3 nM) 
(Mintz et al., 1992) and lower to Q- type (Kd = 200 nM) (Randall and Tsien, 1995). Second, only 
Q-type exhibits a two-exponential function, an obvious peak and slow decline (Budde et al., 
2002). Third, P-type channels are more sensitive to the T-type blocker Miberfradil than Q-type 
channels (Catterall et al., 2005). Based on our results, the transient component of RBCs is likely 
to be Q-type Ca2+ currents. It is possible that in RBCs of mice the P/Q type channels bind with 
different auxiliary subunits or they are regulated in different mechanisms.  
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Functional implications for the expression of P/Q Ca2+ channels in RBCs  
What could be functional roles for the expression of P/Q Ca2+ channels in addition to L-
type Ca2+ channels in RBCs? The RBCs convert synaptic inputs from rod photoreceptors to AII 
amacrine cells in the rod pathway which operate at dim light, scotopic vision. The rod pathway, 
which is extremely sensitive, is capable of encoding light luminance as well as contrast at 
different background light. Although RBCs exhibit a sustained change of membrane potential in 
response to light, the transmitter release from RBCs to AII amacrine cells was found to be 
biphasic, both sustained and transient (Singer and Diamond, 2003). The biphasic synaptic 
transmission has been proposed to be the synaptic mechanism underlining the encoding of light 
luminance and contrast at RBC-All synapses (Oesch and Diamond, 2011). In previous studies, 
the transient transmitter release was considered to be the result of depletion of a readily 
releasable vesicle pool at the terminals of RBCs (Mennerick and Matthews, 1996; von Gersdorff 
and Matthews, 1996; Singer and Diamond, 2006; Jackman et al., 2009).  
The discovery of the expression of two types of HVA Ca2+ channels in RBCs in this 
study raises an alternative possible explanation of the biphasic transmitter release of RBCs. In 
fact, the P/Q type (Cav2.1) subfamily is a major component of Ca2+ channels in triggering 
transmitter release in neuromuscular junctions and the CNS (Olivera et al., 1994), which is 
capable of triggering fast synaptic transmission in the CNS (Catterall, 2011). It is also interesting 
to note that the involvement of L-type Ca2+ channels in triggering transmitter release has been 
considered to be unique to retinal photoreceptor cells and BCs neurons. Since our results show 
that both P/Q and L-type Ca2+ channels are localized at the axon terminals of RBCs, likely both 
Ca2+ channels are involved in synaptic transmission of RBCs. In particular, our results show that 
the transient component is activated at a more hyperpolarization potential than DHP-sensitive 
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Ca2+ currents. Therefore, the P/Q channels could induce transient Ca2+ influx with a small 
membrane depolarization while L-type Ca2+ channels mediate Ca2+ influx at stronger stimulus. 
Although the total calcium influx through P/Q channels is smaller than L-type Ca2+ channels, it 
has better temporal resolution and involve in sensitivity regulation.  Further studies would be 
interesting to determine whether the two types of HVA Ca2+ current could also contribute to the 
encoding of light luminance and contrast at the RBC–AII cell synapses. The finding of the 
expression of two types of HVA Ca2+ channels at the axon terminal of RBCs could be provide 
new insights into the functional role of voltage-gated Ca2+ channels in BC processing.  
Approaches for α1C channel conditional knockout 
In theory, there are two ways to knockout the α1C gene. The first one is by crossing this 
mouse line with the Cre transgenic mouse; the expression of α1C in the Cre-expressing cells will 
be deleted. The other one is intravitreal injection of AAV2/2 virus carrying Cre sequence as used 
in this study (see methods). 
However, the first approach was unsuccessful in our situation, because the Cre-transgenic 
lines do not express fluorescence protein themselves. For our purpose, the Cre-line needs to cross 
with two animal lines:  one is Cre reporter line with fluorescence protein first, and the other one 
is the α1C conditional knockout line. The strong Cre reporter line, B6.Cg-Gt (ROSA) 26Sortm9 
(CAG-tdTomato) Hze/J (referred to as tdTomato reporter line) harbors a combination of the 
CMV early enhancer element and chicken beta-actin (CAG) promoter-driven red fluorescent 
protein (RFP) variant, tdTomato, at the Gt (ROSA) 26Sor locus with a loxP-flanked STOP 
sequence. Then those cells with reporter fluorescence protein expression will indicate the Cre 
existence. Only in these Cre expressing cells, the α1C gene would be knocked out. Moreover, the 
offspring of the triple crossing must be α1C conditional knockout homozygous. Unfortunately, 
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the gene of α1C (MGI: 103013; Ch6; 55.86cm) is on the same chromosome with the reporter Gt 
(ROSA) 26 Sor (MGI: 104735; Ch6; 52.73cm) on Chromosome 6 of mouse. Due to their gene 
sequence locus, it is impossible to obtain offspring with α1C-/- and ROSA26+/+. 
For the reason mentioned above, the second approach to obtain α1C-/- is intravitreal 
injection of AAV2/2 virus carrying Cre-GFP sequence into α1C conditional knockout animal. 
Therefore, those cells transfected by AAV virus had Cre-GFP expression are α1C-/-. We 
developed a virus construct using a modified mGluR6 promoter enhancer that can achieve the 
expression of transgene in BCs, including RBCs. Although the Cre construct carry GFP 
sequence, the fluorescence is too weak for slice recordings. To identify the Cre positive RBCs as 
well as Cre-mediated recombination, the Cre vector as co-injected another AAV virus carrying 
DIO-mCherry (Lu et al., 2013). In this way, those cells with mCherry expression indicate the 
Cre-mediated recombination and, likely, the deletion of α1C gene. Also importantly, this 
approach offers an advantage to eliminate the potential developmental compensation effects.  
Molecular composition of L-type Ca2+ currents in RBCs 
Voltage gated Ca2+ channels in presynaptic terminals trigger neurotransmitter release 
after depolarization. Among the ten types of BC in mouse retina, RBC is a very unique one. In 
morphology aspect, RBCs have large and round axon terminals, the boutons. Regarding to vision 
information processing aspect, RBCs do not directly connect with retinal ganglion cells; they 
superimpose on the existing cone bipolar pathway through AII amacrine cells and A17 amacrine 
cells.  
Although RBCs have been known to express L-type HVA Ca2+ channels, the molecular 
properties of the L-type Ca2+ currents in RBCs still needed to be elucidated. Previous 
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immunostaining studies suggested that L-type Ca2+ channels in RBCs could be formed by α1F, 
α1C, or a1S Ca2+ channel subunits (Specht et al., 2009).   
In this study, by using 1 Ca2+ channel knockout or deficient mouse lines, our results 
show that L-type HVA Ca2+ channels in RBCs are mainly mediated by 1C Ca2+ channels. First, 
we find that the L-type Ca2+ current in RBCs was not altered in 1D knockout mice while only 
moderately reduced in 1F deficient mice. The average current was reduced to 73% in 1F 
deficient mice compared to that of control in wild type. In contrast, the L-type Ca2+ current is 
markedly reduced in the 1C knock-out RBCs. The average current was reduced to 21.7% of the 
control. It should be noted that, the negative results from 1D knockout mice could not exclude 
the possible involvement of 1D in the Ca2+ current in RBCs, because of the potential gene 
compensation that could occur during development in global knockout mouse lines. Similarly, 
the moderate reduction of HVA Ca2+ current in the 1F deficient mice would suggest the 1F 
gene is at least in part involved. The latter could particularly the case because a recent study 
reported the presence of a minor splicing variant of the 1F gene in this 1F deficient mouse 
line. However, our studies of 1C gene knockout were carried out by virus mediated Cre 
recombination in adult 1C conditional knock-out mice. This would largely reduce the 
developmental related gene compensation. Thus, the results from 1C knockout studies suggest 
that the 1C subunit contributes a major component of the L-type Ca2+ current in RBCs. 
Furthermore, considering the results of 1C conditional knockout data, our results suggest that 
the moderate reduction of the Ca2+ current in the 1F deficient mouse line should reflect a small 
contribution of the 1F subunit to the L-type Ca2+ current in RBCs.  
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A previous immunostaining study reported the positive staining of the 1S Ca2+ channel 
in the OPL (Specht et al., 2009).  A more recent study reported that the 1S Ca2+ subunit in the 
retina was a novel isoform co-localized with mGluR6 receptors in the dendritic processes of 
RBCs. However, the same study by qRT-PCR and RNA sequencing reported but the isoform 
only contains transmembrane domains III and IV (Ray et al., 2013) (see Scheme 3). This 
truncated isoform, therefore, is incapable of forming a functional calcium channel. Therefore, the 
expression of functional 1S Ca2+ channels in RBCs is unlikely, consistency with my patch 
clamp recording data and many earlier reports (Pan, 2000; Protti et al., 2000) that RBCs without 
axon terminal have no HVA Ca2+ currents.  
Our results are consistent with the earlier immunostaining results that RBCs express both 
1C and 1F calcium channel subunits. However, it is worth to point out that the 
immunostaining studies of 1C previously showed that α1C is expressed throughout RBCs, 
including cell soma and dendrites in rats (Xu et al., 2002). The latter was not consistent with the 
electrophysiological recordings reported by many earlier studies as well as this study in mice. 
Mutations in the human 1F-subunit cause X-linked congenital stationary night blindness 
(Koschak et al., 2003). The cellular pathophysiology of the disease has been suggested to be 
originate in rod photoreceptors and, also possibly, in RBCs. Since 1F only contributes a small 
component of Ca2+ current in RBCs, our results suggest that the deficiency in 1F mutation is 
mainly at the level of photoreceptors. 
Contribution of Ca2+ channels to BC diversity 
The voltage gated Ca2+ channels in presynaptic terminals are known to play an important 
role in mediating neuronal excitability and neurotransmitter release. Retinal BCs of different 
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types have both HVA Ca2+ currents and LVA Ca2+ currents. Previous studies reported the 
heterogeneous expression of LVA T-type Ca2+ channels among different retinal BCs (Pan, 2000). 
The major finding of this study is the disclosure of the heterogeneous expression of HVA Ca2+ 
channels in BCs. Our results suggest that the differential expression of HVA Ca2+ channels may 
also contribute to the diversity of synaptic transmission in BCs. Our studies provide new insights 
into the roles of voltage-gated Ca2+ channels of BC in retinal processing as well as the molecular 
mechanisms of retinal diseases/disorders that could occur from genetic mutations of voltage-
gated Ca2+ channels. 
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Retinal bipolar cells, conveying visual information from photoreceptors to ganglion cells, 
segregate visual information into multiple parallel pathways through their diversified cell types 
and physiological properties. Voltage-gated Ca2+ channels could be particularly important 
underlying the diversified physiological properties of different BCs. In this dissertation, I 
investigated high-voltage-activated (HVA) calcium currents in retinal bipolar cells in mice. In 
the first part of my dissertation, I characterized multiple bipolar cell-expressing GFP and/or Cre 
transgenic mouse lines. In the second part of my dissertation, by performing whole-cell patch-
clamp recordings, I examined the electrophysiological properties of HVA calcium currents 
among CBCs and between CBCs and RBCs. In particular, the second part of my study focused 
on the investigation of electrophysiological, pharmacological, and molecular properties of HVA 
calcium currents in RBCs. The results of my studies showed that the HVA Ca2+ currents with 
different electrophysiological properties were observed among CBCs, and between CBCs and 
RBCs. First, large HVA Ca2+ currents were observed in OFF CBCs but not in ON-CBCs. Second, 
HVA Ca2+ currents among different bipolar cells were found to show different activation 
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potentials. Furthermore, the HVA Ca2+ currents in RBCs exhibited two components, a sustained 
and a transient component with the latter activated at more negative potentials. My 
pharmacological results indicated that sustained and transient HVA Ca2+ currents originated 
from L- and P/Q type Ca2+ channels, respectively. Using L-type Ca2+ channel knockout or 
deficient mouse lines, my results suggest that the L-type Ca2+ currents in RBCs are mediated 
mainly by 1C Ca2+ channels with a minor component from 1F Ca2+ channels. The studies will 
advance our understanding of the role of voltage-gated  Ca2+ channels in basic visual information 
processing in the retina as well as Ca2+ signaling and Ca2+ channel deficit-related diseases in the 
visual system. 
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